[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 252
1. Zanation AM, Snyderman CH, Carrau RL, Kassam AB, Gardner PA, Prevedello DM: Minimally invasive endoscopic pericranial flap: a new method for endonasal skull base reconstruction. Laryngoscope; 2009 Jan;119(1):13-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This can be due to prior surgical resection or involvement of the nasal septum by sinonasal cancer.
  • The use of a pericranial scalp flap for reconstruction during endonasal skull base surgery using minimally invasive techniques has not been previously reported.
  • METHODS: We performed cadaveric studies to illustrate feasibility of an endoscopic pericranial flap for endonasal skull base reconstruction, then applied this novel technique to an elderly patient after endonasal skull base and dural resection of an esthesioneuroblastoma.
  • [MeSH-major] Endoscopy / methods. Esthesioneuroblastoma, Olfactory / surgery. Minimally Invasive Surgical Procedures / methods. Nasal Cavity / surgery. Nose Neoplasms / surgery. Reconstructive Surgical Procedures / methods. Skull Base Neoplasms / surgery. Surgical Flaps


2. Hanna E, DeMonte F, Ibrahim S, Roberts D, Levine N, Kupferman M: Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results. Arch Otolaryngol Head Neck Surg; 2009 Dec;135(12):1219-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PATIENTS: All patients with biopsy-proved malignant neoplasm of the sinonasal region who were treated with endoscopic resection between 1992 and 2007 were included in the study, and their charts were reviewed for demographics, histopathologic findings, treatment details, and outcome.
  • MAIN OUTCOME MEASURES: Oncologic outcomes, including disease recurrence and survival.
  • RESULTS: Of a total of 120 patients, 93 (77.5%) underwent an exclusively endoscopic approach (EEA) and 27 (22.5%) underwent a cranioendoscopic approach (CEA) in which the surgical resection involved the addition of a frontal or subfrontal craniotomy to the transnasal endoscopic approach.
  • Of the 120 patients, 41% presented with previously untreated disease, 46% presented with persistent disease that had been partially resected, and 13% presented with recurrent disease after prior treatment.
  • The most common site of tumor origin was the nasal cavity (52%), followed by the ethmoid sinuses (28%).
  • Approximately 10% of the tumors had an intracranial epicenter, most commonly around the olfactory groove.
  • Approximately two-thirds (63%) of the patients treated with EEA had a lower (T1-2) disease stage, while 95% of patients treated with CEA had a higher (T3-4) disease stage (P < .001).
  • The most common tumor types were esthesioneuroblastoma (17%), sarcoma (15%), adenocarcinoma (14%), melanoma (14%), and squamous cell carcinoma (13%).
  • With a mean follow-up of 37 months, 18 patients (15%) experienced local recurrence, with a local disease control of 85%.
  • Regional and distant failure occurred as the first sign of disease recurrence in 6% and 5% of patients, respectively.
  • The 5- and 10-year disease-specific survival rates were 87% and 80%, respectively.
  • Disease recurrence and survival did not differ significantly between the EEA group and the CEA group.
  • CONCLUSIONS: To the best of our knowledge, this is the largest US series to date of patients with malignant tumors of the sinonasal tract treated with endoscopic resection.
  • [MeSH-major] Endoscopy. Paranasal Sinus Neoplasms / surgery
  • [MeSH-minor] Adenocarcinoma / surgery. Adolescent. Adult. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / surgery. Chemotherapy, Adjuvant. Child. Craniotomy. Disease-Free Survival. Esthesioneuroblastoma, Olfactory / surgery. Ethmoid Sinus. Female. Humans. Male. Melanoma / surgery. Middle Aged. Neoplasm Recurrence, Local. Nose Neoplasms / mortality. Nose Neoplasms / surgery. Radiotherapy, Adjuvant. Retrospective Studies. Sarcoma / surgery


3. Van Diest D, De Raeve H, Claes J, Parizel PM, De Ridder D, Cras P: Paraneoplastic Opsoclonus-Myoclonus-Ataxia (OMA) syndrome in an adult patient with esthesioneuroblastoma. J Neurol; 2008 Apr;255(4):594-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paraneoplastic Opsoclonus-Myoclonus-Ataxia (OMA) syndrome in an adult patient with esthesioneuroblastoma.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / complications. Esthesioneuroblastoma, Olfactory / pathology. Opsoclonus-Myoclonus Syndrome / etiology. Opsoclonus-Myoclonus Syndrome / immunology. Paranasal Sinus Neoplasms / complications. Paranasal Sinus Neoplasms / pathology
  • [MeSH-minor] Biomarkers, Tumor / analysis. Biomarkers, Tumor / metabolism. Cerebellar Ataxia / drug therapy. Cerebellar Ataxia / immunology. Cerebellar Ataxia / physiopathology. Cerebellum / drug effects. Cerebellum / immunology. Cerebellum / physiopathology. Disease Progression. Dose-Response Relationship, Drug. Ethmoid Sinus / immunology. Ethmoid Sinus / pathology. Female. Humans. Immunosuppressive Agents / administration & dosage. Methylprednisolone / administration & dosage. Middle Aged. Nasal Septum / immunology. Nasal Septum / pathology. Oculomotor Muscles / drug effects. Oculomotor Muscles / immunology. Oculomotor Muscles / physiopathology. Remission Induction. Skin Neoplasms / secondary. Skin Neoplasms / surgery. Treatment Outcome


Advertisement
4. Plasencia YL, Cortés MB, Arencibia DM, Dámaso TM, Contreras IL, Pino AO, Domínguez AC, Brier FL, Delgado YG, Mogollón FJ: Esthesioneuroblastoma recurrence presenting as a syndrome of inappropriate antidiuretic hormone secretion. Head Neck; 2006 Dec;28(12):1142-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Esthesioneuroblastoma recurrence presenting as a syndrome of inappropriate antidiuretic hormone secretion.
  • BACKGROUND: Esthesioneuroblastoma is an uncommon intranasal tumor.
  • These neuroendocrine neoplasms are rarely associated with excess hormone syndromes, and only nine cases of inappropriate antidiuretic hormone syndrome (SIADH) secondary to an esthesioneuroblastoma have been described.
  • We report a unique case of esthesioneuroblastoma recurrence manifesting as SIADH as the solely presenting feature.
  • She had undergone resection of an esthesioneuroblastoma at age 18 with radiotherapy.
  • The patient had undergone annual CT of the nasal area and was considered to be disease free.
  • The resection of the tumor reversed the hyponatremia, and pathologic analysis revealed a recurrence of esthesioneuroblastoma.
  • CONCLUSIONS: Biochemical analysis should be performed in the follow-up of patients with esthesioneuroblastoma.
  • In our case, the biochemical abnormality led to the diagnosis of the recurrence.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / complications. Inappropriate ADH Syndrome / etiology. Nasal Cavity. Neoplasm Recurrence, Local / complications. Nose Neoplasms / complications

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16721738.001).
  • [ISSN] 1043-3074
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


5. Das S, Kirsch CF: Imaging of lumps and bumps in the nose: a review of sinonasal tumours. Cancer Imaging; 2005;5:167-77
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sinonasal disease is one of the most common clinical head and neck pathologies.
  • Although sinus tumours are rare, they portend a poor prognosis, often due to advanced disease at diagnosis.
  • Like most neoplasms, early detection improves prognosis, therefore clinicians and radiologists should be aware of features separating tumours from inflammatory sinus disease.
  • Benign neoplasms reviewed include osteoma, inverting papilloma, and juvenile nasal angiofibroma.
  • Malignant neoplasms reviewed include squamous cell carcinoma, the minor salivary gland tumour, adenoid cystic carcinoma, adenocarcinoma, melanoma, lymphoma, and olfactory neuroblastoma (esthesioneuroblastoma).
  • [MeSH-major] Paranasal Sinus Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] International Cancer Imaging Society.
  • [Cites] Neurochirurgie. 2001 Dec;47(6):542-51 [11915613.001]
  • [Cites] Zhonghua Er Bi Yan Hou Ke Za Zhi. 1998 Dec;33(6):358-60 [11938850.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2002 Aug;128(8):928-35 [12162773.001]
  • [Cites] Ear Nose Throat J. 2002 Aug;81(8):510-4, 516-7 [12199167.001]
  • [Cites] Head Neck. 2002 Sep;24(9):821-9 [12211046.001]
  • [Cites] Am J Rhinol. 2002 Jul-Aug;16(4):221-7 [12222948.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1089-94 [12419436.001]
  • [Cites] Cancer. 1997 Aug 1;80(3):477-88 [9241082.001]
  • [Cites] Clin Otolaryngol Allied Sci. 1998 Feb;23(1):27-33 [9563662.001]
  • [Cites] Eur J Cancer. 1998 Jul;34 Suppl 3:S12-7 [9849403.001]
  • [Cites] Am J Rhinol. 1998 Nov-Dec;12(6):393-8 [9883294.001]
  • [Cites] Am J Rhinol. 1999 Mar-Apr;13(2):111-6 [10219439.001]
  • [Cites] Curr Opin Otolaryngol Head Neck Surg. 2004 Dec;12(6):495-9 [15548906.001]
  • [Cites] Head Neck. 2005 May;27(5):370-5 [15714475.001]
  • [Cites] Head Neck Surg. 1983 Jul-Aug;5(6):508-13 [6885504.001]
  • [Cites] Am J Surg. 1983 Oct;146(4):521-5 [6312826.001]
  • [Cites] Am J Med. 1986 Nov;81(5):911-6 [3776995.001]
  • [Cites] Head Neck Surg. 1979 Nov-Dec;2(2):119-28 [233745.001]
  • [Cites] Laryngoscope. 1987 Nov;97(11):1319-25 [2823033.001]
  • [Cites] Laryngoscope. 1988 Feb;98(2):170-5 [3339927.001]
  • [Cites] Zentralbl Allg Pathol. 1988;134(4-5):409-22 [2849264.001]
  • [Cites] Ann Otolaryngol Chir Cervicofac. 2002 Nov;119(5):271-80 [12464852.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2003 Jan;67(1):59-65 [12560151.001]
  • [Cites] Laryngoscope. 2003 Mar;113(3):502-7 [12616204.001]
  • [Cites] Am J Surg Pathol. 2003 May;27(5):594-611 [12717245.001]
  • [Cites] Rhinology. 2003 Jun;41(2):122-4 [12868380.001]
  • [Cites] Ophthal Plast Reconstr Surg. 2003 May;19(3):237-8 [12918561.001]
  • [Cites] Curr Opin Otolaryngol Head Neck Surg. 2003 Apr;11(2):112-8 [14515089.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2003 Nov;129(11):1186-92 [14623748.001]
  • [Cites] Laryngoscope. 2004 Jan;114(1):106-12 [14710004.001]
  • [Cites] Head Neck. 2004 Jan;26(1):89-93 [14724912.001]
  • [Cites] Laryngoscope. 2004 Feb;114(2):193-200 [14755188.001]
  • [Cites] Acta Neurochir (Wien). 2004 Feb;146(2):179-82 [14963753.001]
  • [Cites] Rev Laryngol Otol Rhinol (Bord). 2003;124(4):235-41 [15038566.001]
  • [Cites] Head Neck. 2004 Apr;26(4):322-30 [15054735.001]
  • [Cites] Am J Otolaryngol. 2004 May-Jun;25(3):178-85 [15124167.001]
  • [Cites] Endocr Pract. 2004 Mar-Apr;10(2):119-24 [15256328.001]
  • [Cites] Leuk Lymphoma. 2004 Jul;45(7):1467-70 [15359650.001]
  • [Cites] Cancer. 1976 Mar;37(3):1571-6 [1260676.001]
  • [Cites] J Otolaryngol. 1977 Oct;6(5):412-22 [926224.001]
  • [Cites] J Otolaryngol. 1978 Aug;7(4):366-70 [691104.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1978 Sep-Oct;87(5 Pt 1):630-2 [214008.001]
  • [Cites] Arch Otolaryngol. 1981 Nov;107(11):677-82 [6271109.001]
  • [Cites] Radiology. 1989 Sep;172(3):763-6 [2772185.001]
  • [Cites] Am J Clin Oncol. 1989 Oct;12(5):387-92 [2552789.001]
  • [Cites] Am J Surg. 1989 Oct;158(4):328-32 [2802037.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 1990;52(3):187-93 [2359595.001]
  • [Cites] Am J Clin Pathol. 1990 Nov;94(5):547-53 [1700595.001]
  • [Cites] Clin Otolaryngol Allied Sci. 1991 Jun;16(3):309-12 [1879080.001]
  • [Cites] CA Cancer J Clin. 1992 Jan-Feb;42(1):19-38 [1728335.001]
  • [Cites] Otolaryngol Head Neck Surg. 1993 Dec;109(6):988-95 [8265198.001]
  • [Cites] Cancer. 1995 Mar 15;75(6):1281-91 [7882278.001]
  • [Cites] J Otolaryngol. 1994 Dec;23(6):430-6 [7897774.001]
  • [Cites] Ir J Med Sci. 1995 Apr-Jun;164(2):139-41 [7607840.001]
  • [Cites] Semin Diagn Pathol. 1996 May;13(2):113-7 [8734417.001]
  • [Cites] Acta Oncol. 1997;36(1):45-50 [9090965.001]
  • [Cites] J Laryngol Otol. 1997 Apr;111(4):372-5 [9176624.001]
  • [Cites] Hum Pathol. 1999 Oct;30(10):1140-5 [10534159.001]
  • [Cites] Acta Otorhinolaryngol Belg. 2000;54(1):45-51 [10719593.001]
  • [Cites] Am J Otolaryngol. 2000 May-Jun;21(3):174-8 [10834551.001]
  • [Cites] Laryngoscope. 2000 Jun;110(6):965-8 [10852514.001]
  • [Cites] Acta Otolaryngol. 2000 Jun;120(4):545-50 [10958410.001]
  • [Cites] J Laryngol Otol. 2000 Sep;114(9):727-30 [11091844.001]
  • [Cites] J Laryngol Otol. 2000 Nov;114(11):891-3 [11144847.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2001 Feb;127(2):141-6 [11177030.001]
  • [Cites] Acta Oncol. 2001;40(1):19-23 [11321654.001]
  • [Cites] Rhinology. 2001 Jun;39(2):66-70 [11486440.001]
  • [Cites] Rev Laryngol Otol Rhinol (Bord). 2001;122(1):21-9 [11499229.001]
  • [Cites] Br J Plast Surg. 2001 Sep;54(6):476-80 [11513507.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2001;13(4):269-72 [11554623.001]
  • [Cites] Cancer. 2001 Dec 15;92(12):3012-29 [11753979.001]
  • (PMID = 16361146.001).
  • [ISSN] 1470-7330
  • [Journal-full-title] Cancer imaging : the official publication of the International Cancer Imaging Society
  • [ISO-abbreviation] Cancer Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 73
  • [Other-IDs] NLM/ PMC1665243
  •  go-up   go-down


6. Yu T, Xu YK, Li L, Jia FG, Duan G, Wu YK, Li HY, Yang RM, Feng J, Ye XH, Qiu YW: Esthesioneuroblastoma methods of intracranial extension: CT and MR imaging findings. Neuroradiology; 2009 Dec;51(12):841-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Esthesioneuroblastoma methods of intracranial extension: CT and MR imaging findings.
  • INTRODUCTION: Esthesioneuroblastoma (ENB) is an aggressive neuroectodermal malignancy in the upper nasal cavity with local infiltration and lymphatic or hematogenous metastasis.
  • The primary tumors were well-defined soft-tissue masses centered in the roof of the nasal cavity eroding into the paranasal sinuses (11/11), the contralateral nasal cavity (4/11), the cranial cavity (5/11), and the fossa orbitalis (3/11).
  • CONCLUSION: Three types of direct intracranial extensions by ENB can be found on CT and MRI: cranio-orbital-nasal-communicating ENB, cranio-nasal-communicating ENB, and orbital-nasal-communicating ENB.
  • [MeSH-major] Brain Neoplasms / diagnosis. Esthesioneuroblastoma, Olfactory / diagnosis. Magnetic Resonance Imaging / methods. Nasal Cavity / diagnostic imaging. Nasal Cavity / pathology. Nose Neoplasms / diagnosis. Tomography, X-Ray Computed / methods


7. Freeman SR, Mitra S, Malik TH, Flanagan P, Selby P: Expression of somatostatin receptors in arginine vasopressin hormone-secreting olfactory neuroblastoma--report of two cases. Rhinology; 2005 Mar;43(1):61-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of somatostatin receptors in arginine vasopressin hormone-secreting olfactory neuroblastoma--report of two cases.
  • OBJECTIVE: Arginine vasopressin hormone-secreting olfactory neuroblastomas are extremely rare, with fewer than twenty cases reported in the literature.
  • CONCLUSIONS: This report demonstrates the potential use of somatastatin analogues in the investigation, follow-up and treatment of patients with olfactory neuroblastoma.
  • [MeSH-major] Arginine Vasopressin / secretion. Esthesioneuroblastoma, Olfactory / metabolism. Esthesioneuroblastoma, Olfactory / secretion. Nasal Cavity. Nose Neoplasms / metabolism. Nose Neoplasms / secretion. Receptors, Somatostatin / biosynthesis

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15844504.001).
  • [ISSN] 0300-0729
  • [Journal-full-title] Rhinology
  • [ISO-abbreviation] Rhinology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Receptors, Somatostatin; 113-79-1 / Arginine Vasopressin
  •  go-up   go-down


8. Tramacere F, Bambace S, De Luca MC, Castagna R, Francavilla MC, Leone A, Monastero S, Fucilli F, Pili G, Portaluri M: Esthesioneuroblastoma treated with external radiotherapy. Case report. Acta Otorhinolaryngol Ital; 2008 Aug;28(4):215-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Esthesioneuroblastoma treated with external radiotherapy. Case report.
  • Esthesioneuroblastoma is a rare tumour arising from the olfactory epithelium of the nasal vault which frequently invades the cranial base and orbit.
  • Esthesioneuroblastoma has a bimodal age distribution between 11 and 20 years and between 51 and 60 years.
  • Esthesioneuroblastoma accounts for approximately 1-5% of intranasal cancers.
  • The case is reported of a 79-year-old female patient with a Kadish stage C tumour with a one-year history of headache, nasal obstruction, anosmia, rhinorrhoea and epistaxis.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / radiotherapy. Paranasal Sinus Neoplasms / radiotherapy

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Head Neck. 2001 Sep;23(9):749-57 [11505485.001]
  • [Cites] Anticancer Res. 1997 Jul-Aug;17(4A):2683-706 [9252701.001]
  • [Cites] Arq Neuropsiquiatr. 2002 Jun;60(2-A):303-7 [12068366.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):486-91 [12243826.001]
  • [Cites] Acta Otolaryngol. 2003 Apr;123(3):433-9 [12737303.001]
  • [Cites] Arch Otolaryngol. 1966 Dec;84(6):644-53 [5957143.001]
  • [Cites] Cancer. 1976 Mar;37(3):1571-6 [1260676.001]
  • [Cites] Surg Clin North Am. 1977 Aug;57(4):751-62 [897964.001]
  • [Cites] Hum Pathol. 1983 Jun;14(6):538-50 [6303940.001]
  • [Cites] Arch Otolaryngol. 1983 Dec;109(12):797-802 [6639453.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1988 Jan;14(1):11-22 [3335447.001]
  • [Cites] Laryngoscope. 1990 Nov;100(11):1199-201 [2233084.001]
  • [Cites] Laryngoscope. 1992 Aug;102(8):843-9 [1495347.001]
  • [Cites] Neurosurgery. 1993 May;32(5):706-14; discussion 714-5 [8492845.001]
  • [Cites] J Otolaryngol. 1997 Feb;26(1):1-7 [9055166.001]
  • [Cites] Strahlenther Onkol. 2002 Apr;178(4):187-91 [12040755.001]
  • (PMID = 18939712.001).
  • [ISSN] 0392-100X
  • [Journal-full-title] Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale
  • [ISO-abbreviation] Acta Otorhinolaryngol Ital
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC2644996
  •  go-up   go-down


9. Casiraghi O, Lefèvre M: [Undifferentiated malignant round cell tumors of the sinonasal tract and nasopharynx]. Ann Pathol; 2009 Sep;29(4):296-312
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Undifferentiated malignant round cell tumors of the sinonasal tract and nasopharynx].
  • [Transliterated title] Tumeurs malignes indifférenciées à cellules rondes des cavités naso-sinusiennes et du nasopharynx.
  • Undifferentiated malignant round cell tumors of the sinonasal tract and nasopharynx comprise of aggressive malignant neoplasms with overlapping morphologic features, which yet are very different and can be identified as carcinoma, lymphoma, sarcoma, melanoma or olfactory neuroblastoma.
  • The use of a panel of immunohistochemical markers and the identification, in some cases, of specific chromosomal translocations are most often required.
  • We describe clinical, morphological, immunohistochemical and molecular features as well as therapeutic management and prognosis of rhabdomyosarcoma (RMS), Ewing sarcoma/primitive neuroectodermic tumor (EWS/PNET), nonkeratinizing nasopharyngeal carcinoma, undifferentiated subtype (UCNT), olfactory neuroblastoma (ONB), small cell carcinoma, neuroendocrine type (SCCNET), sinonasal undifferentiated carcinoma (SNUC) and mucosal melanoma.
  • The most important features of diagnosis will be summarized in two tables.
  • [MeSH-major] Nasopharyngeal Neoplasms / pathology. Paranasal Sinus Neoplasms / pathology
  • [MeSH-minor] Carcinoma / pathology. Esthesioneuroblastoma, Olfactory / pathology. Humans. Melanoma / pathology. Nasal Cavity. Neuroectodermal Tumors, Primitive / pathology. Nose Neoplasms / pathology. Rhabdomyosarcoma / pathology. Sarcoma, Ewing / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19900635.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


10. Buchmann L, Larsen C, Pollack A, Tawfik O, Sykes K, Hoover LA: Endoscopic techniques in resection of anterior skull base/paranasal sinus malignancies. Laryngoscope; 2006 Oct;116(10):1749-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic techniques in resection of anterior skull base/paranasal sinus malignancies.
  • OBJECTIVE: The objective of this study was to examine the role of endoscopic approaches to the resection of anterior skull base and paranasal sinus malignancies at one tertiary care medical center.
  • RESULTS: A total of 78 patients were treated at a tertiary care medical center for malignancies of the paranasal sinuses and anterior skull base.
  • The most common diagnosis was squamous cell carcinoma occurring in 33% of the cases.
  • The remaining pathologies included esthesioneuroblastoma (23%), adenoid cystic carcinoma (15%), melanoma (3%), sinonasal undifferentiated carcinoma (3%), lymphoma (5%), nasopharyngeal carcinoma (4%), and other tumor types (14%).
  • A majority of patients were without evidence of disease at the end of this review.
  • [MeSH-major] Endoscopy / methods. Paranasal Sinus Neoplasms / surgery. Skull Base Neoplasms / surgery
  • [MeSH-minor] Carcinoma / surgery. Carcinoma, Adenoid Cystic / surgery. Carcinoma, Squamous Cell / surgery. Disease-Free Survival. Esthesioneuroblastoma, Olfactory / surgery. Esthetics. Female. Follow-Up Studies. Humans. Lymphoma / surgery. Male. Maxilla / surgery. Melanoma / surgery. Middle Aged. Nasopharyngeal Neoplasms / surgery. Neoadjuvant Therapy. Neoplasm Recurrence, Local / therapy. Retrospective Studies. Survival Rate

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17003718.001).
  • [ISSN] 0023-852X
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. Wang SL, Li SH, Chen WT, Chai CY: Absence of Epstein-Barr virus in olfactory neuroblastoma. Pathology; 2007 Dec;39(6):565-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Absence of Epstein-Barr virus in olfactory neuroblastoma.
  • AIMS: The sinonasal region is a frequent site for Epstein-Barr virus (EBV) related tumours, including nasopharyngeal carcinoma, sinonasal undifferentiated carcinoma and malignant lymphoma.
  • Olfactory neuroblastoma is a rare neoplasm, arises from olfactory epithelium, is found in the upper nasal cavity, and may be confused morphologically with the above tumours.
  • Our aim was to determine whether EBV is associated with olfactory neuroblastoma.
  • METHODS: We collected tissue samples for 16 olfactory neuroblastomas over an 11-year period at Kaohsiung Medical University Hospital.
  • RESULTS: None of the epithelial cells in the 16 cases of olfactory neuroblastoma was positive for EBV.
  • CONCLUSIONS: EBV does not play a major role in the aetiology of olfactory neuroblastoma.
  • [MeSH-major] Epstein-Barr Virus Infections / pathology. Esthesioneuroblastoma, Olfactory / secondary. Herpesvirus 4, Human / isolation & purification. Nasal Cavity / pathology. Nose Neoplasms / pathology

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18027259.001).
  • [ISSN] 0031-3025
  • [Journal-full-title] Pathology
  • [ISO-abbreviation] Pathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Viral
  •  go-up   go-down


12. Batra PS, Luong A, Kanowitz SJ, Sade B, Lee J, Lanza DC, Citardi MJ: Outcomes of minimally invasive endoscopic resection of anterior skull base neoplasms. Laryngoscope; 2010 Jan;120(1):9-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Malignant and benign tumors were managed in 25 (80.6%) and six (19.4%) cases, respectively.
  • Most common histopathologies were squamous cell carcinoma (six), esthesioneuroblastoma (five), mucosal melanoma (five), and sinonasal undifferentiated carcinoma (four).
  • American Joint Committee on Cancer tumor staging was T3N0M0 and T4N0M0 in 14 (56%) and 11 (44%) of the malignant cases, respectively.
  • Twenty-one patients (67.7%) were disease free, five patients (16.1%) were dead from disease, three patients (9.7%) were alive with disease, and two patients (6.5%) died from unrelated causes at mean follow-up of 31.7 months.
  • CONCLUSIONS: This study validated technical feasibility of MIER for diversity of benign and malignant ASB histopathology.
  • This surgical strategy resulted in low complication rate and acceptable disease-free survival in patients with advanced T3 and T4 malignant lesions.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Carcinoma / surgery. Carcinoma, Squamous Cell / surgery. Esthesioneuroblastoma, Olfactory / surgery. Feasibility Studies. Female. Follow-Up Studies. Humans. Male. Melanoma / surgery. Middle Aged. Neoplasm Staging. Retrospective Studies. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19877265.001).
  • [ISSN] 1531-4995
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


13. Nichols AC, Chan AW, Curry WT, Barker FG, Deschler DG, Lin DT: Esthesioneuroblastoma: the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. Skull Base; 2008 Sep;18(5):327-37
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Esthesioneuroblastoma: the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy.
  • OBJECTIVES: To determine the efficacy of craniofacial resection and proton radiation for the management of esthesioneuroblastoma (ENB).
  • MAIN OUTCOME MEASURES: Disease-free and overall survival.
  • Nasal obstruction was the most common presenting symptom.
  • Three patients presented with Kadish stage B disease and seven with stage C.
  • No patient had evidence of cervical or metastatic disease at presentation.
  • The 5-year disease-free and overall survival rates were 90% and 85.7%, respectively, by Kaplan-Meier analysis.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Otolaryngol Head Neck Surg. 2003 Nov;129(11):1186-92 [14623748.001]
  • [Cites] Acta Oncol. 2003;42(8):800-8 [14968940.001]
  • [Cites] Otolaryngol Head Neck Surg. 2004 May;130(5):567-74 [15138422.001]
  • [Cites] Cancer. 1976 Mar;37(3):1571-6 [1260676.001]
  • [Cites] Cancer. 1984 Mar 1;53(5):1036-41 [6362834.001]
  • [Cites] Phys Med Biol. 1984 May;29(5):553-66 [6330772.001]
  • [Cites] Otolaryngol Head Neck Surg. 1989 Dec;101(6):665-9 [2512555.001]
  • [Cites] Am J Clin Oncol. 1990 Apr;13(2):139-43 [2180272.001]
  • [Cites] Ear Nose Throat J. 1990 Nov;69(11):743-6 [2276346.001]
  • [Cites] Laryngoscope. 1992 Aug;102(8):843-9 [1495347.001]
  • [Cites] Neurosurgery. 1993 May;32(5):706-14; discussion 714-5 [8492845.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1993 Nov 15;27(4):835-42 [8244813.001]
  • [Cites] Neurosurgery. 1995 May;36(5):887-96; discussion 896-7 [7791978.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1995 Dec 1;33(5):1239-45 [7493848.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1997 Jan;123(1):34-40 [9006501.001]
  • [Cites] J Otolaryngol. 1997 Feb;26(1):1-7 [9055166.001]
  • [Cites] Neurosurgery. 1998 May;42(5):1023-7; discussion 1027-8 [9588546.001]
  • [Cites] Strahlenther Onkol. 1999 Jun;175 Suppl 2:57-63 [10394399.001]
  • [Cites] Laryngoscope. 1999 Oct;109(10):1539-43 [10522919.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2006 Feb;132(2):134-8 [16490869.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2006 Nov;132(11):1242-9 [17116822.001]
  • [Cites] Skull Base Surg. 1996;6(1):1-8 [17170947.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):758-62 [17398027.001]
  • [Cites] Otolaryngol Head Neck Surg. 2007 Jun;136(6):998-1002 [17547995.001]
  • [Cites] Head Neck. 2000 Sep;22(6):550-8 [10941155.001]
  • [Cites] Laryngoscope. 2001 Mar;111(3):488-93 [11224781.001]
  • [Cites] Lancet Oncol. 2001 Nov;2(11):683-90 [11902539.001]
  • [Cites] J Neurooncol. 2002 Sep;59(3):217-26 [12241118.001]
  • [Cites] Laryngoscope. 2003 Jan;113(1):155-60 [12514401.001]
  • [Cites] Laryngoscope. 2003 Mar;113(3):502-7 [12616204.001]
  • (PMID = 19240832.001).
  • [ISSN] 1531-5010
  • [Journal-full-title] Skull base : official journal of North American Skull Base Society ... [et al.]
  • [ISO-abbreviation] Skull Base
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2637063
  • [Keywords] NOTNLM ; Esthesioneuroblastoma / craniofacial resection / proton radiation
  •  go-up   go-down


14. Maeda K, Sasaki T, Murata Y, Kanasaki M, Terashima T, Kawai H, Yasuda H, Okabe H, Tanaka K: Paraneoplastic cerebellar degeneration in olfactory neuroepithelioma. J Neurol Neurosurg Psychiatry; 2006 Jan;77(1):123-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paraneoplastic cerebellar degeneration in olfactory neuroepithelioma.
  • [MeSH-major] Brain Neoplasms / complications. Brain Neoplasms / pathology. Neuroectodermal Tumors, Primitive, Peripheral / complications. Neuroectodermal Tumors, Primitive, Peripheral / pathology. Olfactory Pathways / pathology. Paraneoplastic Cerebellar Degeneration / complications


15. Renuka IV, Rao BS, Sasank R: Sinonasal neuro endocrine carcinoma extending into orbit - a case report. Indian J Otolaryngol Head Neck Surg; 2008 Jun;60(2):156-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • They should be distinguished from Olfactory Neuroblastomas.
  • Later she developed nasal stuffiness. C.T.
  • Scan revealed a space occupying lesion in the right nostril extending into ethmoid sinus and orbit.
  • Functional endoscopic sinus surgery was done with decompression of the orbit.
  • The biopsy material was obtained from ethmoid sinus and orbit.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1976 Mar;37(3):1571-6 [1260676.001]
  • [Cites] Cancer. 1982 Dec 1;50(11):2388-405 [7139532.001]
  • [Cites] Cancer. 1994 May 15;73(10):2556-62 [8174053.001]
  • [Cites] Cancer. 1997 May 1;79(9):1729-36 [9128989.001]
  • (PMID = 23120526.001).
  • [ISSN] 2231-3796
  • [Journal-full-title] Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
  • [ISO-abbreviation] Indian J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3450525
  • [Keywords] NOTNLM ; Olfactory Neuroblastoma / Paranasal Sinuses / Small Cell Carcinoma / Small cell Neuroendocrine carcinoma
  •  go-up   go-down


16. Sugita Y, Kusano K, Tokunaga O, Mineta T, Abe M, Harada H, Shigemori M: Olfactory neuroepithelioma: an immunohistochemical and ultrastructural study. Neuropathology; 2006 Oct;26(5):400-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Olfactory neuroepithelioma: an immunohistochemical and ultrastructural study.
  • Three cases of olfactory neuroepithelioma are presented in this report.
  • Ultrastructurally, the tumor cells had the differentiation features of olfactory epithelium.
  • Olfactory neuroepithelioma is a rare occurrence and it can be very difficult to distinguish olfactory neuroepithelioma from small cell carcinoma, neuroendocrine carcinoma and so-called "olfactory neuroblastoma" on the basis of hematoxylin and eosin stained sections alone.
  • In controversial cases, a diagnosis of olfactory neuroepithelioma must be substantiated by ultrastructural and immunohistochemical findings, particularly regarding the detection of Ber-EP4 and LH-RH immunoreactivity.
  • [MeSH-major] Biomarkers, Tumor / analysis. Nasal Cavity / ultrastructure. Neuroectodermal Tumors, Primitive, Peripheral / ultrastructure. Nose Neoplasms / ultrastructure
  • [MeSH-minor] Adolescent. Adult. Carcinoma, Neuroendocrine / pathology. Carcinoma, Small Cell / pathology. Diagnosis, Differential. Female. Gonadotropin-Releasing Hormone / metabolism. Humans. Immunohistochemistry. Male. Microscopy, Electron, Transmission. Neoplasm Recurrence, Local / metabolism. Neoplasm Recurrence, Local / ultrastructure

  • Genetic Alliance. consumer health - Neuroepithelioma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17080716.001).
  • [ISSN] 0919-6544
  • [Journal-full-title] Neuropathology : official journal of the Japanese Society of Neuropathology
  • [ISO-abbreviation] Neuropathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / human epithelial antigen-125; 33515-09-2 / Gonadotropin-Releasing Hormone
  •  go-up   go-down


17. Zhao LJ, Gao L, Xu GZ, Li SY, Xiao GL: [Prognostic factors and outcome of esthesioneuroblastoma]. Zhonghua Zhong Liu Za Zhi; 2005 Sep;27(9):561-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Prognostic factors and outcome of esthesioneuroblastoma].
  • OBJECTIVE: To investigate the clinical feature, prognostic factors and the appropriate treatment modality of esthesioneuroblastoma (ENB).
  • In this series, 3 patients had modified Kadish stage A disease, 15 stage B, 22 stage C, and 9 stage D lesion.
  • Overall survival (OS) and disease free survival (DFS) were calculated using Kaplan-Meier method.
  • The 5-year OS of patients with modified Kadish stage A or B disease and those with stage C or D was 78.4% and 49.7% (chi(2) = 2.10, P = 0.15), and the 5-year DFS was 47.1% and 38.4% (chi(2) = 0.08, P = 0.78), respectively.
  • CONCLUSION: Esthesioneuroblastoma is more prevalent in the young male adults than female, usually with locally advanced stage lesion when first diagnosed.
  • Radiotherapy plays an important role in the management of the disease.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / radiotherapy. Esthesioneuroblastoma, Olfactory / surgery. Nose Neoplasms / radiotherapy. Nose Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Child. Combined Modality Therapy. Female. Humans. Lymphatic Metastasis. Male. Middle Aged. Nasal Cavity. Prognosis. Treatment Outcome

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16438858.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


18. Schwedt TJ, Dodick DW, Trentman TL, Zimmerman RS: Response to occipital nerve block is not useful in predicting efficacy of occipital nerve stimulation. Cephalalgia; 2007 Mar;27(3):271-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The objective of this study was to determine if response to occipital nerve block (ONB) predicts response to ONS in patients with chronic, medically intractable headaches.
  • Data were collected regarding analgesic response to ONB and to ONS.
  • Thirteen patients had ONB prior to stimulator implantation.
  • Ten of 13 who had ONB had significant relief of head pain lasting at least 24 h, and three were ONB non-responders.
  • Of the three ONB non-responders, two were ONS responders.
  • Of the two patients who did not have ONB prior to ONS, one was an ONS responder and one was an ONS non-responder.
  • In conclusion, analgesic response to ONB may not be predictive of the therapeutic effect from ONS in patients with medically refractory chronic headaches.
  • [MeSH-major] Cranial Nerves. Electric Stimulation Therapy / methods. Headache / diagnosis. Headache / therapy. Nerve Block / methods. Outcome Assessment (Health Care) / methods

  • MedlinePlus Health Information. consumer health - Headache.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17381559.001).
  • [ISSN] 0333-1024
  • [Journal-full-title] Cephalalgia : an international journal of headache
  • [ISO-abbreviation] Cephalalgia
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] England
  •  go-up   go-down


19. Unger F, Haselsberger K, Walch C, Stammberger H, Papaefthymiou G: Combined endoscopic surgery and radiosurgery as treatment modality for olfactory neuroblastoma (esthesioneuroblastoma). Acta Neurochir (Wien); 2005 Jun;147(6):595-601; discussion 601-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined endoscopic surgery and radiosurgery as treatment modality for olfactory neuroblastoma (esthesioneuroblastoma).
  • OBJECT: Treatment of esthesioneuroblastoma (olfactory neuroblastoma) has been considerably improved by microsurgical techniques.
  • A novel therapeutic approach that combines endoscopic sinus surgery and Gamma Knife radiosurgery is presented here.
  • Taking into account the rarity of the disease the present study comprises a relatively large series of patients treated in a similar manner.
  • This series comprises 12 newly diagnosed esthesioneuroblastomas.
  • Paranasal and nasal endoscopic sinus surgery was performed.
  • All patients complained of nasal discharge and crusts.
  • CONCLUSIONS: Based on the favourable results recorded so far, the combination of endoscopic sinus surgery and radiosurgery can be considered a promising treatment option for esthesioneuroblastoma that merits further consideration.
  • [MeSH-major] Endoscopy. Esthesioneuroblastoma, Olfactory / surgery. Nasal Cavity / surgery. Nose Neoplasms / surgery. Radiosurgery
  • [MeSH-minor] Adult. Aged. Combined Modality Therapy. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Staging. Treatment Outcome


20. Sinha SK, Abrams JH, Houle TT, Weller RS: Ultrasound-guided obturator nerve block: an interfascial injection approach without nerve stimulation. Reg Anesth Pain Med; 2009 May-Jun;34(3):261-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND AND OBJECTIVES: For knee surgery, obturator nerve block (ONB) has been shown to enhance postoperative analgesia provided by femoral block.
  • This preliminary observational study evaluated the success of an ultrasound-guided ONB without the additional use of nerve stimulation.
  • METHODS: Thirty patients scheduled for knee surgery under general anesthesia with nerve block for postoperative analgesia had ONB performed using USG and injection of 10 mL 0.5% ropivacaine with epinephrine.


21. Boo H, Hogg JP: Nasal cavity neoplasms: a pictorial review. Curr Probl Diagn Radiol; 2010 Mar-Apr;39(2):54-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nasal cavity neoplasms: a pictorial review.
  • A pictorial review of nasal cavity neoplasms is provided for the reader to gain or refresh information about these neoplasms.
  • Retrospective case review of pathologically and clinically proven nasal cavity neoplasms are shown with multiple modalities including computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography/computed tomography (PET/CT) to illustrate the findings and complement a succinct review of this category of disease.
  • Examples include squamous cell cancer, adenoid cystic cancer, esthesioneuroblastoma, inverted papilloma, juvenile nasal angiofibroma, melanoma, lymphoma, sarcoma, and benign nasal histiocytoma.
  • [MeSH-major] Nasal Cavity. Nose Neoplasms / diagnosis
  • [MeSH-minor] Angiofibroma / diagnosis. Carcinoma, Adenoid Cystic / diagnosis. Carcinoma, Squamous Cell / diagnosis. Chondrosarcoma / diagnosis. Diagnosis, Differential. Esthesioneuroblastoma, Olfactory / diagnosis. Histiocytoma, Benign Fibrous / diagnosis. Humans. Magnetic Resonance Imaging. Melanoma / diagnosis. Papilloma, Inverted / diagnosis. Positron-Emission Tomography. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Mosby, Inc. All rights reserved.
  • (PMID = 20113866.001).
  • [ISSN] 1535-6302
  • [Journal-full-title] Current problems in diagnostic radiology
  • [ISO-abbreviation] Curr Probl Diagn Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Papadogeorgakis N, Petsinis V, Eleftheriades E, Dimtsas S, Protopappa D, Alexandridis C: Large olfactory neuroblastoma (esthesioneuroblastoma) surgically treated with an Altemir technique modification: a case report. Oral Maxillofac Surg; 2009 Sep;13(3):171-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Large olfactory neuroblastoma (esthesioneuroblastoma) surgically treated with an Altemir technique modification: a case report.
  • INTRODUCTION: Olfactory neuroblastomas are rare malignant tumors that usually occur in the upper nasal cavity.
  • The purpose of this paper is to present a case of a large olfactory neuroblastoma filling the entire nasal cavity, treated with an Altemir technique modification.
  • METHODS: A 39-year-old woman presented with a large tumor of the nasal cavity.
  • After the laboratory examinations, the tumor was classified as a Kadish stage A olfactory neuroblastoma.
  • RESULTS: Histopathology revealed a Hyams grade III olfactory neuroblastoma completely removed.
  • CONCLUSIONS: Large olfactory neuroblastomas filling the entire nasal cavity extending back to the postnasal space can be completely removed using a transfacial approach as the Altemir technique modification is.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / surgery. Nasal Cavity / surgery. Nose Neoplasms / surgery. Otorhinolaryngologic Surgical Procedures / methods

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Laryngoscope. 1999 Oct;109(10):1539-43 [10522919.001]
  • [Cites] Laryngoscope. 2003 Mar;113(3):502-7 [12616204.001]
  • [Cites] Int J Oral Maxillofac Surg. 1998 Feb;27(1):53-7 [9506301.001]
  • [Cites] Br J Oral Maxillofac Surg. 1991 Aug;29(4):230-6 [1655014.001]
  • [Cites] Ear Nose Throat J. 2004 Oct;83(10):668, 670 [15586860.001]
  • [Cites] J Maxillofac Surg. 1986 Jun;14(3):165-70 [3014030.001]
  • [Cites] Cancer. 2008 Feb 15;112(4):885-91 [18189294.001]
  • [Cites] Am J Rhinol. 2001 Jul-Aug;15(4):271-9 [11554661.001]
  • [Cites] Head Neck. 2005 Feb;27(2):138-49 [15654688.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1960 Aug;13:908-12 [14422003.001]
  • [Cites] Lancet Oncol. 2001 Nov;2(11):683-90 [11902539.001]
  • [Cites] Neurosurgery. 1998 May;42(5):1023-7; discussion 1027-8 [9588546.001]
  • [Cites] Head Neck. 2000 Sep;22(6):550-8 [10941155.001]
  • [Cites] AJNR Am J Neuroradiol. 1993 Sep-Oct;14 (5):1167-71 [8237698.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2006 Feb;132(2):134-8 [16490869.001]
  • [Cites] Cancer. 1976 Mar;37(3):1571-6 [1260676.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 2002 Nov-Dec;64(6):454-6 [12499774.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2007 Sep;133(9):888-96 [17875855.001]
  • [Cites] Laryngoscope. 1992 Aug;102(8):843-9 [1495347.001]
  • [Cites] Cancer. 1976 Dec;38(6):2494-502 [1000479.001]
  • [Cites] Laryngoscope. 1990 Nov;100(11):1199-201 [2233084.001]
  • (PMID = 19506925.001).
  • [ISSN] 1865-1550
  • [Journal-full-title] Oral and maxillofacial surgery
  • [ISO-abbreviation] Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


23. Luong A, Citardi MJ, Batra PS: Management of sinonasal malignant neoplasms: defining the role of endoscopy. Am J Rhinol Allergy; 2010 Mar-Apr;24(2):150-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of sinonasal malignant neoplasms: defining the role of endoscopy.
  • The five most common pathologies were squamous cell carcinoma (21), melanoma (10), esthesioneuroblastoma (8), adenocarcinoma (7), and sinonasal undifferentiated carcinoma (3).
  • For those patients undergoing definitive treatment, the disease-free and overall survival rates were 69.2 and 84.6% at mean of 34.5 and 42.7 months, respectively.
  • CONCLUSION: The endoscope is a versatile tool for management of sinonasal malignant neoplasms.
  • [MeSH-major] Carcinoma, Squamous Cell / therapy. Endoscopy. Nose Neoplasms / therapy. Paranasal Sinuses / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Chemotherapy, Adjuvant. Disease Progression. Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Metastasis. Neoplasm Staging. Survival Analysis


24. Ladziński P, Majchrzak H, Kaspera W, Maliszewski M, Majchrzak K, Tymowski M, Adamczyk P: Direct and remote outcome after treatment of tumours involving the central skull base with the extended subfrontal approach. Neurol Neurochir Pol; 2009 Jan-Feb;43(1):22-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Less frequent symptoms were: paresis/paralysis of the 6th cranial nerve, psychoorganic syndrome, impaired visual acuity, nasal obstruction and headache.
  • The most frequent histological diagnosis was chordoma (19%), meningioma (15%), followed by haemangiopericytoma, fibroma and esthesioneuroblastoma (12%).
  • For removal of malignant tumours at the same location, ESA is an alternative to a combination of transcranial approach and one of the craniofacial approaches.
  • [MeSH-minor] Adolescent. Adult. Aged. Chordoma / surgery. Esthesioneuroblastoma, Olfactory / surgery. Female. Fibroma / surgery. Hemangiopericytoma / surgery. Humans. Male. Meningioma / surgery. Middle Aged. Retrospective Studies. Survival Rate. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19353441.001).
  • [ISSN] 0028-3843
  • [Journal-full-title] Neurologia i neurochirurgia polska
  • [ISO-abbreviation] Neurol. Neurochir. Pol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


25. Englund C, Alvord EC Jr, Folkerth RD, Silbergeld D, Born DE, Small R, Hevner RF: NeuN expression correlates with reduced mitotic index of neoplastic cells in central neurocytomas. Neuropathol Appl Neurobiol; 2005 Aug;31(4):429-38
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the other tumours (one extraventricular neurocytoma, one desmoplastic medulloblastoma, one olfactory neuroblastoma, one ganglioglioma and one anaplastic ganglioglioma), the Ki-67 labelling index was always at least fourfold lower in NeuN(+) cells than in NeuN(-) cells.

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16008827.001).
  • [ISSN] 0305-1846
  • [Journal-full-title] Neuropathology and applied neurobiology
  • [ISO-abbreviation] Neuropathol. Appl. Neurobiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / Nerve Tissue Proteins
  •  go-up   go-down


26. Mhawech-Fauceglia P, Herrmann FR, Bshara W, Odunsi K, Terracciano L, Sauter G, Cheney RT, Groth J, Penetrante R, Mhawech-Fauceglia P: Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody. J Clin Pathol; 2007 Jun;60(6):694-700
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody.
  • AIM: To determine expression of FLI-1 in various benign and malignant neoplasms, by immunohistochemical analysis on 4323 tumours using multiple tumour microarrays, as well as on whole sections.
  • RESULTS: FLI-1 was expressed in 46/62 EWS/PNETs, 2/3 olfactory neuroblastomas, 7/102 small cell carcinomas of the lung, 10/34 MCCs, 1/14 rhabdomyosarcoma, 19/132 non-Hodgkin's lymphomas, 2/3 DSRCTs, and in 53/74 benign and malignant vascular tumours.
  • This finding should be kept in mind, especially when using FLI-1 as a marker for finding the primary origin of poorly differentiated metastatic tumour.
  • [MeSH-minor] Carcinoma, Small Cell / diagnosis. Carcinoma, Small Cell / metabolism. Diagnosis, Differential. Humans. Immunoenzyme Techniques. Neoplasms, Germ Cell and Embryonal / diagnosis. Neoplasms, Germ Cell and Embryonal / metabolism. Neuroectodermal Tumors, Primitive / diagnosis. Neuroectodermal Tumors, Primitive / metabolism. Protein Array Analysis / methods. Sarcoma, Ewing / diagnosis. Sarcoma, Ewing / metabolism. Sensitivity and Specificity

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 2001 Aug;25(8):1061-6 [11474291.001]
  • [Cites] Am J Surg Pathol. 2000 Dec;24(12):1657-62 [11117787.001]
  • [Cites] Oncogene. 2001 Sep 10;20(40):5747-54 [11607824.001]
  • [Cites] Am J Surg Pathol. 2002 Mar;26(3):320-7 [11859203.001]
  • [Cites] Hum Pathol. 2003 Oct;34(10):994-1000 [14608532.001]
  • [Cites] Hum Pathol. 2004 Jan;35(1):122-8 [14745734.001]
  • [Cites] Mod Pathol. 2004 May;17(5):547-52 [15001993.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2004 Jun;12(2):160-5 [15354743.001]
  • [Cites] Am J Clin Pathol. 2004 Nov;122(5):721-7 [15491968.001]
  • [Cites] Nat Med. 1998 Jul;4(7):844-7 [9662379.001]
  • [Cites] Int J Dev Biol. 1998 May;42(4):561-72 [9694627.001]
  • [Cites] Histopathology. 2005 Jun;46(6):622-34 [15910593.001]
  • [Cites] Am J Surg Pathol. 2005 Aug;29(8):1025-33 [16006796.001]
  • [Cites] Am J Surg Pathol. 2005 Sep;29(9):1184-93 [16096408.001]
  • [Cites] Int J Gynecol Pathol. 2006 Apr;25(2):151-4 [16633064.001]
  • [Cites] Semin Diagn Pathol. 2000 Aug;17(3):216-24 [10968707.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2001 Sep;9(3):255-60 [11556754.001]
  • (PMID = 16917000.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Proto-Oncogene Protein c-fli-1
  • [Other-IDs] NLM/ PMC1955051
  •  go-up   go-down


27. Taneja AK, Reis F, Queiroz LS, Zanardi Vde A: Esthesioneuroblastoma. Arq Neuropsiquiatr; 2009 Sep;67(3A):704-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Esthesioneuroblastoma.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / diagnosis. Nasal Cavity. Nose Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19722056.001).
  • [ISSN] 1678-4227
  • [Journal-full-title] Arquivos de neuro-psiquiatria
  • [ISO-abbreviation] Arq Neuropsiquiatr
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


28. Brown SR: Esthesioneuroblastoma. Otolaryngol Head Neck Surg; 2007 Nov;137(5):835-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Esthesioneuroblastoma.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / pathology. Nose Neoplasms / pathology

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Otolaryngol Head Neck Surg. 2008 Feb;138(2):258
  • (PMID = 17967657.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


29. Zollinger LV, Wiggins RH 3rd, Cornelius RS, Phillips CD: Retropharyngeal lymph node metastasis from esthesioneuroblastoma: a review of the therapeutic and prognostic implications. AJNR Am J Neuroradiol; 2008 Sep;29(8):1561-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retropharyngeal lymph node metastasis from esthesioneuroblastoma: a review of the therapeutic and prognostic implications.
  • Esthesioneuroblastoma (ENB) is a malignant neoplasm of the olfactory epithelium.
  • Metastasis of ENBs to retropharyngeal lymph nodes is an important finding on imaging examinations that alters staging and treatment.
  • The CT and MR imaging findings from the cases of 4 patients with ENB with retropharyngeal metastatic disease are reviewed.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / diagnosis. Esthesioneuroblastoma, Olfactory / secondary. Nasal Cavity / pathology. Nasal Cavity / radiography. Nose Neoplasms / diagnosis. Pharynx / pathology. Pharynx / radiography

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18499797.001).
  • [ISSN] 1936-959X
  • [Journal-full-title] AJNR. American journal of neuroradiology
  • [ISO-abbreviation] AJNR Am J Neuroradiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 15
  •  go-up   go-down


30. García-Santana SM, Rodríguez JA, Serrano L, Hedges TR 3rd: Esthesioneuroblastoma presenting with complete external ophthalmoplegia. Semin Ophthalmol; 2009 Nov-Dec;24(6):245-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Esthesioneuroblastoma presenting with complete external ophthalmoplegia.
  • Neuroimaging revealed a mass involving the medial wall of the left cavernous sinus, without orbital involvement.
  • Biopsy of the mass provided a pathologic diagnosis of esthesioneuroblastoma.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / pathology. Nasal Cavity / pathology. Nose Neoplasms / pathology. Ophthalmoplegia / pathology

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19954376.001).
  • [ISSN] 1744-5205
  • [Journal-full-title] Seminars in ophthalmology
  • [ISO-abbreviation] Semin Ophthalmol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


31. Bumm K, Grizzi F, Franceschini B, Koch M, Iro H, Wurm J, Ceva-Grimaldi G, Dimmler A, Cobos E, Dioguardi N, Sinha UK, Kast WM, Chiriva-Internati M: Sperm protein 17 expression defines 2 subsets of primary esthesioneuroblastoma. Hum Pathol; 2005 Dec;36(12):1289-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sperm protein 17 expression defines 2 subsets of primary esthesioneuroblastoma.
  • Esthesioneuroblastomas (ENBs) are rare malignant tumors of the nasal vault, the origin, diagnosis, and management of which are still subjects of discussion.
  • We here show that sperm protein 17 (Sp17) is expressed in the ciliated cells of the normal olfactory epithelium and in a proportion of primary ENB lesions.
  • We found an association between Sp17 expression and metastases at relapse (P = .035), chromogranin expression (P = .014), and a female sex prevalence.
  • [MeSH-major] Carrier Proteins / metabolism. Esthesioneuroblastoma, Olfactory / secondary. Nasal Cavity / pathology. Nose Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Antigens, Surface. Biomarkers, Tumor / metabolism. Child. Chromogranins / metabolism. Female. Humans. Immunoenzyme Techniques. Male. Middle Aged. Olfactory Mucosa / metabolism. Olfactory Mucosa / pathology

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16311122.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Surface; 0 / Biomarkers, Tumor; 0 / Carrier Proteins; 0 / Chromogranins; 0 / SPA17 protein, human
  •  go-up   go-down


32. Laforest C, Selva D, Crompton J, Leibovitch I: Orbital invasion by esthesioneuroblastoma. Ophthal Plast Reconstr Surg; 2005 Nov;21(6):435-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Orbital invasion by esthesioneuroblastoma.
  • PURPOSE: Esthesioneuroblastoma is a rare malignancy arising from the olfactory mucosa in the nasal fossa, which can invade the orbit producing ophthalmic symptoms and signs.
  • The purpose of this study was to present a case series and review the literature to assess the characteristics of orbital involvement by esthesioneuroblastoma.
  • METHODS: Retrospective case series of all patients treated for biopsy-proven esthesioneuroblastoma at the Royal Adelaide Hospital between 1992 and 2004.
  • Mean time from onset of symptoms to diagnosis was 17 months (range, 2 to 24 months).
  • All patients who had or went on to have development of orbital invasion had advanced disease at diagnosis.
  • CONCLUSIONS: Orbital invasion by esthesioneuroblastoma is not uncommon.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / pathology. Nasal Cavity. Nose Neoplasms / pathology. Orbit / pathology
  • [MeSH-minor] Adult. Aged. Biopsy. Fatal Outcome. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Retrospective Studies

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16304521.001).
  • [ISSN] 0740-9303
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


33. Piro NA, Cummins CC: An unusual P-P double bond formed via phospha-Wittig transformation of a terminal PO complex. J Am Chem Soc; 2009 Jul 1;131(25):8764-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual P-P double bond formed via phospha-Wittig transformation of a terminal PO complex.
  • The terminal phosphorus monoxide complex (OP)Mo(N[(t)Bu]Ar)(3), 1 (Ar = 3,5-Me(2)C(6)H(3)), undergoes an O-for-PSiR(3) metathesis reaction with the niobium phosphinidene complex (i)Pr(3)SiPNb(N[CH(2)(t)Bu]Ar)(3), 2, to generate the oxoniobium complex ONb(N[CH(2)(t)Bu]Ar)(3), 3, and the diphosphenido complex (i)Pr(3)SiPPMo(N[(t)Bu]Ar)(3), 4.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19505095.001).
  • [ISSN] 1520-5126
  • [Journal-full-title] Journal of the American Chemical Society
  • [ISO-abbreviation] J. Am. Chem. Soc.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. Suzuki M, Sakurai H, Seno S, Hoshi J, Ogawa T, Arikata M, Tojima I, Kitanishi T, Tanaka H, Shimizu T: [Endoscopic resection of benign and malignant tumors in the nasal cavity and paranasal sinus]. Nihon Jibiinkoka Gakkai Kaiho; 2005 Jul;108(7):724-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Endoscopic resection of benign and malignant tumors in the nasal cavity and paranasal sinus].
  • Endoscopic resection of nasal and paranasal sinus tumors is more aesthetic and less invasive than conventional resection, such as Luc's operation and lateral rhinotomy.
  • Subjects were patients with benign lesions in the nasal cavity, medial wall of the maxillary sinus, ethmoid sinus, and/or sphenoid sinus without concurrent malignant lesions.
  • Although patients selection for malignant tumor excision was based on (1) possible en bloc resection, (2) low-grade malignant tumors, and (3) tumors in the nasal cavity and adjoining paranasal sinus, the final decision was made individual.
  • Subjects were 23 patients with benign tumor (10 inverted papilloma, 9 hemangioma, 2 juvenile angiofibroma, and 2 other tumors) and 4 with malignant tumor (olfactory neuroblastoma, acinic cell carcinoma, squamous cell carcinoma, and chondroid chordoma) in the nasal and paranasal sinus.
  • The endoscopic excision of benign lesions in the nasal and paranasal sinus is thus as effective as conventional radical surgery.
  • Endoscopic removal of malignant lesions remains controversial because of the small number of patients and short postoperative observation.
  • [MeSH-major] Endoscopy. Nasal Cavity. Nose Neoplasms / surgery. Paranasal Sinus Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16107047.001).
  • [ISSN] 0030-6622
  • [Journal-full-title] Nihon Jibiinkoka Gakkai kaiho
  • [ISO-abbreviation] Nippon Jibiinkoka Gakkai Kaiho
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


35. Diaz EM Jr, Johnigan RH 3rd, Pero C, El-Naggar AK, Roberts DB, Barker JL, DeMonte F: Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck; 2005 Feb;27(2):138-49
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center.
  • BACKGROUND: Olfactory neuroblastoma (ONB) is a rare tumor arising from the olfactory neuroepithelium.
  • METHODS: Thirty patients treated for ONB at The University of Texas M. D.
  • The diagnosis of ONB was histologically confirmed for each patient.
  • Nine patients whose disease was initially stage C had a recurrence.
  • Anderson Cancer Center approach to ONB is complete surgical resection, usually involving a craniofacial approach, with postoperative radiation therapy.
  • This approach seems to be curative in early-stage disease.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / diagnosis. Esthesioneuroblastoma, Olfactory / therapy. Nasal Cavity. Nose Neoplasms / diagnosis. Nose Neoplasms / therapy
  • [MeSH-minor] Academic Medical Centers. Adolescent. Adult. Aged. Combined Modality Therapy. Disease-Free Survival. Female. Humans. Male. Middle Aged. Neoplasm Staging. Retrospective Studies. Survival Rate. Texas. Treatment Outcome

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2004 Wiley Periodicals, Inc.
  • (PMID = 15654688.001).
  • [ISSN] 1043-3074
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


36. Porter AB, Bernold DM, Giannini C, Foote RL, Link MJ, Olsen KD, Moynihan TJ, Buckner JC: Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neurooncol; 2008 Nov;90(2):201-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma.
  • BACKGROUND: Esthesioneuroblastoma (ENB) is a rare tumor arising from the olfactory epithelium in the upper nasal cavity.
  • METHODS: A retrospective review of 76 patients treated at the Mayo Clinic for esthesioneuroblastoma from 1976 to 2003 was performed to evaluate adjuvant chemotherapy (AC) in these patients.
  • CONCLUSIONS: This small retrospective series suggests that adjuvant therapy for patients with high grade, Stage C esthesioneuroblastoma is of benefit following complete resection.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Esthesioneuroblastoma, Olfactory / drug therapy. Nasal Cavity. Nose Neoplasms / drug therapy

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Clin Oncol. 1990 Apr;13(2):139-43 [2180272.001]
  • [Cites] Neurosurgery. 1993 May;32(5):706-14; discussion 714-5 [8492845.001]
  • [Cites] Cancer. 2004 Nov 15;101(10):2257-60 [15484215.001]
  • [Cites] Cancer. 1984 Mar 1;53(5):1036-41 [6362834.001]
  • [Cites] Otolaryngol Head Neck Surg. 2007 Jun;136(6):998-1002 [17547995.001]
  • [Cites] Head Neck. 2005 Feb;27(2):138-49 [15654688.001]
  • [Cites] Lancet Oncol. 2001 Nov;2(11):683-90 [11902539.001]
  • [Cites] Cancer. 1989 Feb 15;63(4):638-42 [2536584.001]
  • [Cites] Neurosurgery. 1998 May;42(5):1023-7; discussion 1027-8 [9588546.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1993 Nov 15;27(4):835-42 [8244813.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2006 Feb;132(2):134-8 [16490869.001]
  • [Cites] Cancer. 1976 Mar;37(3):1571-6 [1260676.001]
  • [Cites] J Clin Oncol. 2002 Jan 1;20(1):357-8 [11773199.001]
  • [Cites] Cancer. 2002 May 15;94(10):2623-34 [12173330.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1997 Jan;123(1):34-40 [9006501.001]
  • (PMID = 18633576.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


37. Emerson LL, Layfield LJ, Frame R: Pleomorphic olfactory neuroblastoma (esthesioneuroblastoma): histopathological findings and clinical course. Histopathology; 2007 Sep;51(3):430-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pleomorphic olfactory neuroblastoma (esthesioneuroblastoma): histopathological findings and clinical course.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / pathology. Nasal Cavity / pathology. Nose Neoplasms / pathology
  • [MeSH-minor] Adult. Combined Modality Therapy. Ethmoid Sinus / pathology. Female. Humans. Treatment Outcome


38. Umeda Y, Matsumoto M, Aiso S, Nishizawa T, Nagano K, Arito H, Fukushima S: Inhalation carcinogenicity and toxicity of 1,2-dichloropropane in rats. Inhal Toxicol; 2010 Nov;22(13):1116-26
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Thirteen-week exposure to DCP induced hyperplasia in the respiratory epithelium and atrophy of the olfactory epithelium at 125 ppm and above.
  • Two-year exposure to DCP significantly increased incidences of papilloma in the nasal cavity of male and female rats exposed to 500 ppm DCP.
  • In addition, three cases of esthesioneuroepithelioma were observed in the DCP-exposed male rats.
  • Total nasal tumors increased in a concentration-dependent manner.
  • Atrophy of the olfactory epithelium, inflammation of the respiratory epithelium, and squamous cell metaplasia were also seen in the 2-year study.
  • These results demonstrate that DCP is a nasal carcinogen in rats.
  • [MeSH-major] Carcinogens / toxicity. Nasal Cavity / pathology. Nose Neoplasms / chemically induced. Propane / analogs & derivatives

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • Hazardous Substances Data Bank. PROPANE .
  • Hazardous Substances Data Bank. 1,2-DICHLOROPROPANE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21070183.001).
  • [ISSN] 1091-7691
  • [Journal-full-title] Inhalation toxicology
  • [ISO-abbreviation] Inhal Toxicol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Carcinogens; RRZ023OFWL / propylene dichloride; T75W9911L6 / Propane
  •  go-up   go-down


39. Nicolai P, Battaglia P, Bignami M, Bolzoni Villaret A, Delù G, Khrais T, Lombardi D, Castelnuovo P: Endoscopic surgery for malignant tumors of the sinonasal tract and adjacent skull base: a 10-year experience. Am J Rhinol; 2008 May-Jun;22(3):308-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic surgery for malignant tumors of the sinonasal tract and adjacent skull base: a 10-year experience.
  • The most frequent histotypes encountered were adenocarcinoma (37%), squamous cell carcinoma (13.6%), olfactory neuroblastoma (12%), mucosal melanoma (9.2%), and adenoid cystic carcinoma (7.1%).
  • The 5-year disease-specific survival was 91.4 +/- 3.9% and 58.8 +/- 8.6% (p = 0.0004) for the EEA and CEA group, respectively.
  • CONCLUSION: To the best of our knowledge, this is the largest series reported to date of malignant tumors of the sinonasal tract and adjacent skull base treated with pure endoscopic or cranioendoscopic techniques.
  • A 5-year disease-specific survival of 91.4% and 58.8% for the EEA and the CEA groups, respectively, seem to indicate that endoscopic surgery, when properly planned and in expert hands, may be a valid alternative to standard surgical approaches for the management of malignancies of the sinonasal tract.
  • [MeSH-major] Endoscopy / methods. Otorhinolaryngologic Surgical Procedures / methods. Paranasal Sinus Neoplasms / surgery. Skull Base Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Female. Follow-Up Studies. Humans. Incidence. Italy / epidemiology. Length of Stay. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Nose. Retrospective Studies. Skull. Survival Rate / trends. Time Factors. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18588765.001).
  • [ISSN] 1050-6586
  • [Journal-full-title] American journal of rhinology
  • [ISO-abbreviation] Am J Rhinol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


40. Kim HJ, Cho HJ, Kim KS, Lee HS, Kim HJ, Jung E, Yoon JH: Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma. J Craniomaxillofac Surg; 2008 Jan;36(1):47-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma.
  • INTRODUCTION: Olfactory neuroblastoma is a very aggressive tumour with high rates of locoregional recurrence and distant metastasis.
  • In this study, we present our experience and treatment outcomes for salvage therapy in patients with recurrent olfactory neuroblastoma.
  • MATERIAL AND METHODS: We retrospectively analysed 17 patients treated for advanced olfactory neuroblastoma during the last 15 years.
  • RESULTS: The disease-free 5-year survival rate was 48% in all patients and 42% in the 17 patients with recurrence or distant metastasis.
  • In 15% of patients with a clinical stage N0 at initial diagnosis, nodal recurrence developed and was successfully treated with salvage therapy.
  • CONCLUSION: Complete surgical resection, including craniofacial resection and postoperative radiotherapy without elective neck dissection, is the preferred approach in the treatment of advanced olfactory neuroblastoma.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / secondary. Esthesioneuroblastoma, Olfactory / therapy. Nasal Cavity. Neoplasm Recurrence, Local / therapy. Nose Neoplasms / therapy. Salvage Therapy
  • [MeSH-minor] Adult. Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Child. Disease-Free Survival. Female. Humans. Male. Middle Aged. Neck Dissection. Prognosis. Radiotherapy, High-Energy. Retrospective Studies

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18312791.001).
  • [ISSN] 1010-5182
  • [Journal-full-title] Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
  • [ISO-abbreviation] J Craniomaxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


41. Park MC, Weaver CE Jr, Donahue JE, Sampath P: Intracavitary chemotherapy (Gliadel) for recurrent esthesioneuroblastoma: case report and review of the literature. J Neurooncol; 2006 Mar;77(1):47-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracavitary chemotherapy (Gliadel) for recurrent esthesioneuroblastoma: case report and review of the literature.
  • Esthesioneuroblastoma is an uncommon malignancy of the nasal vault with a treatment regimen consisting of surgical resection followed by radiotherapy for primary lesions and addition of chemotherapy for patients with advanced, recurrent or metastatic lesions.
  • We report a case of a 39-year-old female with a history of esthesioneuroblastoma, previously treated with resection, radiation and chemotherapy, presenting with a recurrent disease that was successfully treated with re-resection and placement of Gliadel) wafers in the surgical resection cavity.
  • The novel option of controlled-release and local delivery of a chemotherapeutic agent for treatment of recurrent esthesioneuroblastoma should be recognized and considered.
  • [MeSH-major] Antineoplastic Agents, Alkylating / administration & dosage. Carmustine / administration & dosage. Esthesioneuroblastoma, Olfactory / drug therapy. Nasal Cavity / pathology. Neoplasm Recurrence, Local / drug therapy. Nose Neoplasms / drug therapy

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Carmustine .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Laryngoscope. 1999 Oct;109(10):1539-43 [10522919.001]
  • [Cites] Neurosurgery. 1993 May;32(5):706-14; discussion 714-5 [8492845.001]
  • [Cites] Cancer. 2004 Nov 15;101(10):2257-60 [15484215.001]
  • [Cites] Cancer. 1994 May 15;73(10):2556-62 [8174053.001]
  • [Cites] Neurosurgery. 2003 Aug;53(2):255-69; discussion 259-60 [12925239.001]
  • [Cites] Neuro Oncol. 2003 Apr;5(2):79-88 [12672279.001]
  • [Cites] Cancer Control. 1998 Mar;5(2):130-137 [10761024.001]
  • [Cites] Lancet Oncol. 2001 Nov;2(11):683-90 [11902539.001]
  • [Cites] Anticancer Res. 1997 Jul-Aug;17(4A):2683-706 [9252701.001]
  • [Cites] J Neurooncol. 1987;5(1):47-50 [3598620.001]
  • [Cites] Otolaryngol Head Neck Surg. 2004 May;130(5):567-74 [15138422.001]
  • [Cites] Neurosurgery. 1998 May;42(5):1023-7; discussion 1027-8 [9588546.001]
  • [Cites] Cancer. 1979 Sep;44(3):1087-94 [383268.001]
  • [Cites] J Control Release. 2001 Jul 6;74(1-3):63-7 [11489483.001]
  • [Cites] Head Neck. 2000 Sep;22(6):550-8 [10941155.001]
  • [Cites] Neurosurg Clin N Am. 2000 Oct;11(4):693-701 [11082179.001]
  • [Cites] Cancer. 1976 Mar;37(3):1571-6 [1260676.001]
  • [Cites] Head Neck. 2001 Sep;23(9):749-57 [11505485.001]
  • [Cites] Curr Opin Otolaryngol Head Neck Surg. 2003 Apr;11(2):112-8 [14515089.001]
  • [Cites] Laryngoscope. 1992 Aug;102(8):843-9 [1495347.001]
  • [Cites] Invest New Drugs. 2004 Jan;22(1):27-37 [14707492.001]
  • [Cites] Laryngoscope. 1990 Nov;100(11):1199-201 [2233084.001]
  • [Cites] Lancet. 1995 Apr 22;345(8956):1008-12 [7723496.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2003 Nov;129(11):1186-92 [14623748.001]
  • [Cites] Neurosurgery. 1998 May;42(5):1029-37 [9588547.001]
  • (PMID = 16283436.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 0 / Biocompatible Materials; 0 / Decanoic Acids; 0 / Drug Carriers; 0 / Drug Implants; 0 / Polyesters; 0 / carmustine with prolifeprosan 20; 90409-78-2 / decanedioic acid-4,4'-(1,3-propanediylbis(oxy))bis(benzoic acid) copolymer; U68WG3173Y / Carmustine
  • [Number-of-references] 27
  •  go-up   go-down


42. Cheng C, Long Xb: [Diagnosis and treatment of esthesioneuroblastoma in the nasal cavity and sinuses]. Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct;30(10):2402-3, 2405
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnosis and treatment of esthesioneuroblastoma in the nasal cavity and sinuses].
  • OBJECTIVE: To discuss the clinical characteristics, diagnosis and treatment of esthesioneuroblastoma (ENB).
  • METHODS: The clinical data of 7 patients with ENB were analyzed retrospectively, and the clinical characteristics, diagnosis, surgical approaches and prognosis of the disease were discussed.
  • CONCLUSION: Early diagnosis of ENB can be difficult.
  • Transnasal-frontal approach with nasal endoscope is effective approach to ENB treatment, and the patients may benefit from postoperative radiotherapy and chemotherapy to improve the prognosis.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory. Nose Neoplasms. Paranasal Sinus Neoplasms
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Nasal Cavity. Retrospective Studies. Young Adult

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20965857.001).
  • [ISSN] 1673-4254
  • [Journal-full-title] Nan fang yi ke da xue xue bao = Journal of Southern Medical University
  • [ISO-abbreviation] Nan Fang Yi Ke Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


43. Castelnuovo P, Bignami M, Delù G, Battaglia P, Bignardi M, Dallan I: Endonasal endoscopic resection and radiotherapy in olfactory neuroblastoma: our experience. Head Neck; 2007 Sep;29(9):845-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endonasal endoscopic resection and radiotherapy in olfactory neuroblastoma: our experience.
  • BACKGROUND: Our aim was to evaluate the efficacy of a bimodal method of treatment consisting in endoscopic resection followed by radiotherapy in patients with olfactory neuroblastoma (ON).
  • CONCLUSIONS: This method of treatment causes minimal injury to the patients, reduces side effects, and improves the quality of life of those with olfactory neuroblastoma.
  • [MeSH-major] Endoscopy / methods. Esthesioneuroblastoma, Olfactory / radiotherapy. Esthesioneuroblastoma, Olfactory / surgery. Nose Neoplasms / radiotherapy. Nose Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Nasal Cavity. Quality of Life. Radiotherapy, Adjuvant. Retrospective Studies

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 Wiley Periodicals, Inc. Head Neck, 2007.
  • (PMID = 17427966.001).
  • [ISSN] 1043-3074
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Pan F, Yu XH, Mo XX, You JL, Wang C, Chen H, Jiang GC: [Raman active vibrations of aluminosilicates]. Guang Pu Xue Yu Guang Pu Fen Xi; 2006 Oct;26(10):1871-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The result shows a decrease tendency in Raman frequencies in the 800-1200 cm(-1) frequency region with increase in four-coordinated Al content, which is assigned to the Si--Onb symmetry stretching vibrations.
  • The Raman spectra in the 700-800 cm(-1) frequency region is attributed to Al-Onb symmetry stretching vibrations.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17205741.001).
  • [ISSN] 1000-0593
  • [Journal-full-title] Guang pu xue yu guang pu fen xi = Guang pu
  • [ISO-abbreviation] Guang Pu Xue Yu Guang Pu Fen Xi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


45. Thompson L: Olfactory neuroblastoma. Ear Nose Throat J; 2006 Sep;85(9):569-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Olfactory neuroblastoma.
  • [MeSH-major] Neuroblastoma / pathology. Nose Neoplasms / pathology

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17044420.001).
  • [ISSN] 0145-5613
  • [Journal-full-title] Ear, nose, & throat journal
  • [ISO-abbreviation] Ear Nose Throat J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


46. Araújo Rde P, Gomes EF, Menezes DB, Ferreira LM, Rios AS: Rare nasosinusal tumors: case series and literature review. Braz J Otorhinolaryngol; 2008 Mar-Apr;74(2):307-14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumors of the nasal cavity and paranasal sinuses are unusual pathologies found in clinical practice.
  • The aim of this study is to describe a series of rare nasosinusal tumors, including esthesioneuroblastomas, central giant cell granulomas, extramedullary plasmocytomas, nasosinusal hemangiopericytomas, neurofibromas and cemento-ossifying fibromas, diagnosed at the Fortaleza General Hospital.
  • We, hereby, briefly review each of the aforementioned pathologies, stressing the need for a precise histological diagnosis for proper treatment in each case.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / diagnosis. Granuloma, Giant Cell / diagnosis. Hemangiopericytoma / diagnosis. Nasal Cavity. Paranasal Sinus Neoplasms / diagnosis. Plasmacytoma / diagnosis
  • [MeSH-minor] Adolescent. Adult. Epistaxis / etiology. Female. Humans. Middle Aged. Nasal Obstruction / etiology. Neoplasm Recurrence, Local / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18568214.001).
  • [ISSN] 1808-8694
  • [Journal-full-title] Brazilian journal of otorhinolaryngology
  • [ISO-abbreviation] Braz J Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Brazil
  • [Number-of-references] 30
  •  go-up   go-down


47. Castelnuovo PG, Delù G, Sberze F, Pistochini A, Cambria C, Battaglia P, Bignami M: Esthesioneuroblastoma: endonasal endoscopic treatment. Skull Base; 2006 Feb;16(1):25-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Esthesioneuroblastoma: endonasal endoscopic treatment.
  • OBJECTIVES: To illustrate endoscopic techniques used in the treatment of esthesioneuroblastoma and to advocate this method of management followed by radiation therapy in selected cases.
  • METHODS: A retrospective case series of 10 patients with esthesioneuroblastomas treated between 1999 and 2004 at a tertiary referral center using endonasal techniques.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Otorhinolaryngol Belg. 1999;53(3):199-205 [10635393.001]
  • [Cites] Head Neck. 2000 Sep;22(6):550-8 [10941155.001]
  • [Cites] Laryngorhinootologie. 2000 Dec;79(12):736-42 [11199456.001]
  • [Cites] Laryngoscope. 2003 Jan;113(1):155-60 [12514401.001]
  • [Cites] Cancer. 1976 Mar;37(3):1571-6 [1260676.001]
  • [Cites] Head Neck. 1992 Nov-Dec;14(6):477-82 [1468921.001]
  • [Cites] Rhinology. 1998 Mar;36(1):12-4 [9569435.001]
  • [Cites] Neth J Med. 2003 Dec;61(12):414-6 [15025418.001]
  • [Cites] Am J Surg. 1981 Oct;142(4):456-8 [7283046.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1993 Nov 15;27(4):835-42 [8244813.001]
  • [Cites] Acta Neurochir (Wien). 1997;139(9):839-44 [9351988.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1997 Dec;123(12):1312-7 [9413360.001]
  • [Cites] Laryngoscope. 1992 Aug;102(8):843-9 [1495347.001]
  • (PMID = 16880898.001).
  • [ISSN] 1531-5010
  • [Journal-full-title] Skull base : official journal of North American Skull Base Society ... [et al.]
  • [ISO-abbreviation] Skull Base
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1408078
  •  go-up   go-down


48. Suriano M, De Vincentiis M, Colli A, Benfari G, Mascelli A, Gallo A: Endoscopic treatment of esthesioneuroblastoma: a minimally invasive approach combined with radiation therapy. Otolaryngol Head Neck Surg; 2007 Jan;136(1):104-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic treatment of esthesioneuroblastoma: a minimally invasive approach combined with radiation therapy.
  • OBJECTIVE: In a retrospective analysis we discuss our experience in the treatment of olfactory neuroblastoma (ON), a rare tumor of the sinonasal tract.
  • STUDY DESIGN AND SETTING: Nine patients with olfactory neuroblastoma were treated at the Bolognini Hospital of Seriate and at the Department of Otolaryngology of "La Sapienza" University of Rome combining endoscopic surgery and postoperative radiation therapy.
  • RESULTS: All patients, over an average follow-up which ranged from 26 through 60 months, are actually alive with non evidence of disease (NED).
  • CONCLUSIONS: Despite the short follow-up in this small series of patients, we suggest endoscopic surgery combined with postoperative radiation therapy as an alternative to the conventional modalities of treatment for esthesioneuroblastoma in selected cases.
  • [MeSH-major] Endoscopy. Esthesioneuroblastoma, Olfactory / surgery

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17210343.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


49. Zhang LW, Zhang MS, Qi J, Zhang JT, Li GL, Luo L, Wang ZC: Management of intracranial invasive olfactory neuroblastoma. Chin Med J (Engl); 2007 Feb 5;120(3):224-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of intracranial invasive olfactory neuroblastoma.
  • BACKGROUND: Olfactory neuroblastoma (ONB) is a rare tumor that often arise from the nasal cavity.
  • The aim of this study was to investigate the clinical characteristics and treatments of intracranial invasive ONB.
  • METHODS: Between July 2001 and August 2005, 5 patients with intracranial invasive ONB were treated in our department.
  • RESULTS: The ONB was resected totally in the 4 patients.
  • In all the patients, nasal obstruction was alleviated without cerebrospinal fluid leakage.
  • CONCLUSION: ONB has no specific symptoms.
  • Intracranial ONB should be resected as far as possible, and treated by radiotherapy after the operation.
  • [MeSH-major] Brain Neoplasms / surgery. Esthesioneuroblastoma, Olfactory / surgery

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17355826.001).
  • [ISSN] 0366-6999
  • [Journal-full-title] Chinese medical journal
  • [ISO-abbreviation] Chin. Med. J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  •  go-up   go-down


50. Mattavelli F, Pizzi N, Pennacchioli E, Radaelli S, Calarco G, Quattrone P, Patelli L, Spinelli P: Esthesioneuroblastoma metastatic to the trachea. Acta Otorhinolaryngol Ital; 2009 Jun;29(3):164-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Esthesioneuroblastoma metastatic to the trachea.
  • Esthesioneuroblastoma is a rare tumour, for which a multimodal approach, including a combination of surgery and radiation, appears to provide the best disease-free and overall survival.
  • The case is reported here of a patient who developed metastatic esthesioneuroblastoma to the trachea 18 months after primary surgery and radiation therapy.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / secondary. Nasal Cavity. Nose Neoplasms / pathology. Tracheal Neoplasms / secondary

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Curr Treat Options Oncol. 2005 Nov;6(6):509-18 [16242055.001]
  • [Cites] Laryngoscope. 2006 Oct;116(10):1749-54 [17003718.001]
  • [Cites] Acta Neurochir (Wien). 2005 Jun;147(6):595-601; discussion 601-2 [15806328.001]
  • [Cites] Head Neck. 2005 Mar;27(3):224-31 [15627260.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1964 Sep;73:569-82 [14215937.001]
  • [Cites] Proc Staff Meet Mayo Clin. 1954 Jul 14;29(14):403-5 [13185995.001]
  • [Cites] Respir Med. 1998 Mar;92(3):599-600 [9692131.001]
  • [Cites] J Surg Oncol. 1996 Aug;62(4):249-52 [8691837.001]
  • [Cites] J Thorac Cardiovasc Surg. 1993 Sep;106(3):537-42 [8361198.001]
  • [Cites] Neurosurgery. 1993 May;32(5):706-14; discussion 714-5 [8492845.001]
  • [Cites] Head Neck Surg. 1987 Nov-Dec;10(2):102-6 [3507417.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1982 Nov-Dec;91(6 Pt 1):648-51 [6184006.001]
  • [Cites] Cancer. 1976 Mar;37(3):1571-6 [1260676.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1971 Apr;80(2):192-206 [4323842.001]
  • [Cites] Laryngoscope. 2003 Dec;113(12):2086-90 [14660907.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2003 Nov;129(11):1186-92 [14623748.001]
  • [Cites] Laryngoscope. 2003 Nov;113(11):1935-8 [14603051.001]
  • [Cites] Curr Opin Otolaryngol Head Neck Surg. 2003 Apr;11(2):112-8 [14515089.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2003 May;260(5):244-7 [12750912.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2007 Mar;133(3):276-80 [17372086.001]
  • [Cites] Lung Cancer. 2000 May;28(2):163-70 [10717334.001]
  • [Cites] Head Neck. 2001 Sep;23(9):749-57 [11505485.001]
  • (PMID = 20140164.001).
  • [ISSN] 1827-675X
  • [Journal-full-title] Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale
  • [ISO-abbreviation] Acta Otorhinolaryngol Ital
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC2815355
  • [Keywords] NOTNLM ; Esthesioneuroblastoma / Malignant tumours / Trachea / Tracheal metastasis
  •  go-up   go-down


51. Huang Q, Wu H, Wang Z, Zhang Z, Jia H: [Diagnosis and treatment of lateral skull base tumors in pediatric]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Aug;22(16):734-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnosis and treatment of lateral skull base tumors in pediatric].
  • OBJECTIVE: To explore the diagnosis and treatment of lateral skull base tumors in children.
  • One had schwannoma of the trigeminal nerve, one had malignant melanoma, one had fibroma in temporal bone, one had chordoma, two had rhabdomyosarcoma, two had esthesioneuroblastoma.
  • The other 7 cases of benign or malignant tumors underwent surgery in different approaches.
  • CONCLUSION: Tumors in lateral skull base in children were rare, of which malignant tumors were more common compared to benign lesions.
  • CT and MRI are helpful in evaluating extent of disease and preoperative planning.
  • Radiation therapy and chemotherapy could be used for malignant tumors preoperatively and postoperatively.
  • [MeSH-major] Skull Base Neoplasms / diagnosis. Skull Base Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18975775.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


52. Eich HT, Müller RP, Micke O, Kocher M, Berthold F, Hero B: Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment? Strahlenther Onkol; 2005 Jun;181(6):378-84
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
  • BACKGROUND AND PURPOSE: Only 3% of all malignant intranasal tumors are esthesioneuroblastomas (ENB) and only 20% of these rare neuroectodermal tumors are diagnosed up to 20 years of age.
  • To investigate the influence of radio- and chemotherapy, the treatment and course of the disease in children and adolescents with ENB were analyzed retrospectively.
  • Median age at diagnosis was 14.0 years (range, 5-20 years).
  • Complete resection (R0) was achieved in 15 out of 17 patients with surgery including all five patients with preoperative chemotherapy due to unresectable primary at diagnosis.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / radiotherapy. Nasal Cavity. Nose Neoplasms / radiotherapy
  • [MeSH-minor] Adolescent. Adult. Antineoplastic Agents / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Child. Child, Preschool. Combined Modality Therapy. Female. Humans. Male. Neoplasm Staging. Retrospective Studies. Survival Analysis

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15925980.001).
  • [ISSN] 0179-7158
  • [Journal-full-title] Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
  • [ISO-abbreviation] Strahlenther Onkol
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


53. Dahabreh I, Janinis D, Stamatelopoulos AG, Bontozoglou N, Dahabreh J: Surgical resection of esthesioneuroblastoma metastasis to the chest wall. J Thorac Oncol; 2007 Jan;2(1):93-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical resection of esthesioneuroblastoma metastasis to the chest wall.
  • The patient's history was significant for esthesioneuroblastoma at the age of 24; multiple recurrences of the tumor had been treated with surgery, radiotherapy, and chemotherapy.
  • Histologic examination confirmed metastatic esthesioneuroblastoma.
  • The patient developed generalized disease and finally died 2 years after surgery.
  • This case demonstrates the long natural history of this rare neoplasm and the need for close follow-up of patients so that they can be treated early.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / secondary. Esthesioneuroblastoma, Olfactory / surgery. Nose Neoplasms / pathology. Thoracic Neoplasms / secondary. Thoracic Neoplasms / surgery. Thoracic Wall
  • [MeSH-minor] Female. Humans. Middle Aged. Nasal Cavity

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17410019.001).
  • [ISSN] 1556-1380
  • [Journal-full-title] Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • [ISO-abbreviation] J Thorac Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


54. Seccia V, Lenzi R, Casani AP, Muscatello L: Ectopic olfactory neuroblastoma arising in the pterygopalatine fossa. Otolaryngol Head Neck Surg; 2010 Mar;142(3):460-1
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ectopic olfactory neuroblastoma arising in the pterygopalatine fossa.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / surgery. Pterygopalatine Fossa. Skull Neoplasms / surgery

  • Genetic Alliance. consumer health - Neuroblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20172404.001).
  • [ISSN] 1097-6817
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


55. Rischin D, Coleman A: Sinonasal malignancies of neuroendocrine origin. Hematol Oncol Clin North Am; 2008 Dec;22(6):1297-316, xi
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The sinonasal malignancies of putative neuroendocrine origin-esthesioneuroblastoma, sinonasal neuroendocrine carcinoma, sinonasal undifferentiated carcinoma, and sinonasal small cell carcinoma-are uncommon malignancies that frequently present with locally advanced disease.

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19010275.001).
  • [ISSN] 0889-8588
  • [Journal-full-title] Hematology/oncology clinics of North America
  • [ISO-abbreviation] Hematol. Oncol. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 77
  •  go-up   go-down


56. Kim BJ, Kim DW, Kim SW, Han DH, Kim DY, Rhee CS, Lee CH: Endoscopic versus traditional craniofacial resection for patients with sinonasal tumors involving the anterior skull base. Clin Exp Otorhinolaryngol; 2008 Sep;1(3):148-53
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The number of malignant and benign lesions was 40 and 6 cases respectively.
  • The most common diagnosis was olfactory neuroblastoma occurring in 41% of the cases followed by squamous cell carcinoma and malignant melanoma.
  • The overall five-year survival rate for patients with malignant tumors of the anterior skull base was 47.4%.
  • Out of 19 patients with olfactory neuroblastomas, 10 patients had TCFR and six among them died of their disease.
  • Nine patients underwent ECFR, and none of them died of their disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Rhinol. 2007 Jan-Feb;21(1):89-94 [17283568.001]
  • [Cites] Laryngoscope. 2001 Mar;111(3):488-93 [11224781.001]
  • [Cites] Skull Base. 2006 Feb;16(1):15-8 [16880896.001]
  • [Cites] Laryngoscope. 2006 Jun;116(6):982-6 [16735899.001]
  • [Cites] Laryngorhinootologie. 2005 Dec;84(12):884-91 [16358197.001]
  • [Cites] Neurosurg Focus. 2002 May 15;12(5):e4 [16119902.001]
  • [Cites] Otolaryngol Clin North Am. 2005 Feb;38(1):133-44, ix [15649504.001]
  • [Cites] Cancer. 2004 Nov 15;101(10):2257-60 [15484215.001]
  • [Cites] Am J Surg. 1963 Nov;106:698-703 [14078719.001]
  • [Cites] Am J Rhinol. 1999 Jul-Aug;13(4):303-10 [10485018.001]
  • [Cites] Am J Otolaryngol. 1997 Nov-Dec;18(6):431-3 [9395024.001]
  • [Cites] Neurosurgery. 1998 May;42(5):1029-37 [9588547.001]
  • [Cites] Neurosurgery. 1996 Mar;38(3):471-9; discussion 479-80 [8837798.001]
  • [Cites] Head Neck. 1994 Jul-Aug;16(4):307-12 [8056574.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1992 Sep;118(9):913-7 [1503715.001]
  • [Cites] Am J Surg. 1988 Sep;156(3 Pt 1):187-90 [3421426.001]
  • [Cites] Otolaryngol Head Neck Surg. 1989 Dec;101(6):665-9 [2512555.001]
  • [Cites] Am J Surg. 1987 Oct;154(4):352-8 [3661836.001]
  • [Cites] Head Neck Surg. 1986 Jul-Aug;8(6):429-35 [3721885.001]
  • [Cites] Am J Rhinol. 2004 Jul-Aug;18(4):239-46 [15490571.001]
  • [Cites] Laryngoscope. 2003 Dec;113(12):2086-90 [14660907.001]
  • [Cites] Otolaryngol Clin North Am. 2001 Dec;34(6):1123-42, ix [11728937.001]
  • [Cites] Laryngoscope. 2006 Oct;116(10):1749-54 [17003718.001]
  • (PMID = 19434247.001).
  • [ISSN] 1976-8710
  • [Journal-full-title] Clinical and experimental otorhinolaryngology
  • [ISO-abbreviation] Clin Exp Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2671747
  • [Keywords] NOTNLM ; Endoscopic craniofacial resection / Nose neoplasms / Skull base
  •  go-up   go-down


57. Barua N, Hilton DA, Mukonoweshuro W, Khalil H, Pobereskin L: Persistent CSF Rhinorrhoea, Pneumocephalus, and Recurrent Meningitis Following Misdiagnosis of Olfactory Neuroblastoma. Case Rep Med; 2010;2010
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Persistent CSF Rhinorrhoea, Pneumocephalus, and Recurrent Meningitis Following Misdiagnosis of Olfactory Neuroblastoma.
  • Histological examination of an endonasal transethmoidal biopsy suggested a diagnosis of olfactory neuroblastoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20811561.001).
  • [ISSN] 1687-9635
  • [Journal-full-title] Case reports in medicine
  • [ISO-abbreviation] Case Rep Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2929619
  •  go-up   go-down


58. Tseng J, Michel MA, Loehrl TA: Peripheral cysts: a distinguishing feature of esthesioneuroblastoma with intracranial extension. Ear Nose Throat J; 2009 Jun;88(6):E14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peripheral cysts: a distinguishing feature of esthesioneuroblastoma with intracranial extension.
  • Esthesioneuroblastoma is a rare malignancy that arises in the olfactory epithelium.
  • We report an interesting case of esthesioneuroblastoma in an 82-year-old man that included an unusual but characteristic imaging feature of this tumor: cysts at the tumor-brain interface.
  • At 2 years of follow-up, he remained disease-free.
  • [MeSH-major] Brain Diseases / pathology. Brain Neoplasms / pathology. Cysts / pathology. Esthesioneuroblastoma, Olfactory / pathology. Nose Neoplasms / pathology
  • [MeSH-minor] Aged, 80 and over. Biopsy. Cranial Fossa, Anterior / pathology. Diagnosis, Differential. Endoscopy. Gadolinium. Humans. Magnetic Resonance Imaging. Male. Paranasal Sinuses / pathology. Tomography, X-Ray Computed. Treatment Outcome


59. Ozer E, Bapna S, Agrawal A, Schuller DE: Maxillary removal and reinsertion: a favorable approach for extensive anterior cranial base tumors. Otolaryngol Head Neck Surg; 2010 Mar;142(3):322-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sixty-two (80%) patients had malignant lesions.
  • The most commonly encountered malignant neoplasm was squamous cell cancer (40.3%), followed by esthesioneuroblastoma (24.1%), adenoid cystic cancer (8%), and other neoplasms (27.4%).
  • Nasal asymmetry was the most common long-term complication (17.9%), followed by plate-associated problems (10.2%) and midface asymmetry (10.2%).
  • [MeSH-minor] Adult. Aged. Child. Esthesioneuroblastoma, Olfactory / surgery. Humans. Maxilla / surgery. Middle Aged. Postoperative Complications / epidemiology. Tomography, X-Ray Computed. Young Adult

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 American Academy of Otolaryngology-Head and Neck Surgery Foundation. Published by Mosby, Inc. All rights reserved.
  • (PMID = 20172374.001).
  • [ISSN] 1097-6817
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


60. Chacón-Moya E, Gallegos-Hernández JF, Piña-Cabrales S, Cohn-Zurita F, Goné-Fernández A: Cranial vault reconstruction using computer-designed polyetheretherketone (PEEK) implant: case report. Cir Cir; 2009 Nov-Dec;77(6):437-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CLINICAL CASE: We report the case of a patient who was diagnosed with esthesioneuroblastoma and was treated with anterior craniofacial resection and radiotherapy.

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20433788.001).
  • [ISSN] 0009-7411
  • [Journal-full-title] Cirugía y cirujanos
  • [ISO-abbreviation] Cir Cir
  • [Language] eng; spa
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Mexico
  • [Chemical-registry-number] 0 / Biocompatible Materials; 0 / Ketones; 30IQX730WE / Polyethylene Glycols; 31694-16-3 / polyetheretherketone
  •  go-up   go-down


61. Mori R, Sakai H, Kato M, Hida T, Nakajima M, Fukuda T, Fukunaga M, Abe T: [Olfactory neuroblastoma with spinal metastasis: case report]. No Shinkei Geka; 2007 May;35(5):503-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Olfactory neuroblastoma with spinal metastasis: case report].
  • Olfactory neuroblastoma is a rare tumor of the nasal cavity.
  • We report a case of olfactory neuroblastoma with cauda equina metastases.
  • A 49-year old male had undergone surgery twice previously; the first for olfactory neuroblastoma in October, 1990, and the second for its intracranial and orbital metastasis in September, 1999.
  • The mass was partially removed and histologically diagnosed as olfactory neuroblastoma metastasis.
  • Olfactory neuroblastoma with spinal metastasis is rare and only 11 cases have been reported in the literature.
  • A very poor prognosis was observed in the patients of olfactory neuroblastoma with spinal metastasis.
  • Olfactory neuroblastoma is a radiosensitive tumor, and radiotherapy for spinal metastasis was reported to be effective.
  • The patient with olfactory neuroblastoma should be observed carefully even though no local recurrence had been detected over 10 years.
  • [MeSH-major] Cauda Equina. Esthesioneuroblastoma, Olfactory / secondary. Esthesioneuroblastoma, Olfactory / surgery. Nasal Cavity. Nose Neoplasms / pathology. Nose Neoplasms / surgery. Peripheral Nervous System Neoplasms / secondary

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17491347.001).
  • [ISSN] 0301-2603
  • [Journal-full-title] No shinkei geka. Neurological surgery
  • [ISO-abbreviation] No Shinkei Geka
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


62. Gupta NP, Ansari MS, Nabi G: National survey on orthotopic neobladder. Int Urol Nephrol; 2007;39(1):143-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of all institutions 12 (50%) did not prefer the orthotopic neobladder (ONB) reconstruction.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Wound Ostomy Continence Nurs. 1995 Jan;22(1):58-63 [7704145.001]
  • [Cites] Rozhl Chir. 1996 Apr;75(4):222-6 [8768999.001]
  • [Cites] Arch Ital Urol Androl. 1996 Dec;68(5):293-8 [9026229.001]
  • [Cites] J Urol. 1999 Feb;161(2):422-7; discussion 427-8 [9915417.001]
  • [Cites] J Urol. 1995 May;153(5):1432-8 [7714959.001]
  • [Cites] J Urol. 1988 Jan;139(1):39-42 [3336101.001]
  • [Cites] J Urol. 2000 Jul;164(1):10-3 [10840413.001]
  • [Cites] J Urol. 1990 Sep;144(3):666-9 [2388323.001]
  • [Cites] Br J Urol. 1993 Jun;71(6):700-6 [8343898.001]
  • [Cites] World J Urol. 1996;14(2):112-6 [8731128.001]
  • [Cites] World J Urol. 1996;14(1):15-21 [8646235.001]
  • [Cites] World J Urol. 1996;14(1):29-39 [8646238.001]
  • [Cites] Urology. 1999 Jul;54(1):44-9 [10414725.001]
  • [Cites] J Urol. 1991 Jan;145(1):51-5 [1984098.001]
  • [Cites] World J Urol. 1996;14(1):40-6 [8646240.001]
  • [Cites] World J Urol. 1996;14(1):9-14 [8646245.001]
  • [Cites] World J Urol. 2000 Oct;18(5):330-7 [11131310.001]
  • [Cites] J Urol. 1975 Mar;113(3):317-23 [1090760.001]
  • [Cites] World J Urol. 1996;14(1):22-6 [8646236.001]
  • [Cites] World J Urol. 1996;14(1):3-8 [8646239.001]
  • [Cites] J Urol. 2003 Mar;169(3):834-42 [12576795.001]
  • [Cites] Semin Urol Oncol. 1997 Aug;15(3):154-60 [9394910.001]
  • [Cites] J Urol. 2000 Jan;163(1):212-4 [10604350.001]
  • [Cites] Semin Urol Oncol. 1997 Aug;15(3):184-8 [9394914.001]
  • [Cites] World J Urol. 1996;14(1):27-8 [8646237.001]
  • (PMID = 17171422.001).
  • [ISSN] 0301-1623
  • [Journal-full-title] International urology and nephrology
  • [ISO-abbreviation] Int Urol Nephrol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


63. Takagi M, Shiraiwa K, Kusuoka O, Tamura K: A Case of Olfactory Neuroblastoma Induced in A Rat by N-Nitrosobis(2-hydroxypropyl)amine. J Toxicol Pathol; 2010 Jun;23(2):111-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A Case of Olfactory Neuroblastoma Induced in A Rat by N-Nitrosobis(2-hydroxypropyl)amine.
  • In the present paper, a case of olfactory neuroblastoma (ONB) induced in a rat by BHP is described.
  • Histologically, the tumor arose in the posterior nasal cavity and consisted of small round cells and elongate cells with scant basophilic cytoplasm.
  • These results indicate that the present tumor is the first case of ONB induced in a rat by BHP treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22272021.001).
  • [ISSN] 1881-915X
  • [Journal-full-title] Journal of toxicologic pathology
  • [ISO-abbreviation] J Toxicol Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Other-IDs] NLM/ PMC3234646
  • [Keywords] NOTNLM ; BHP / N-nitrosobis(2-hydroxypropyl)amine / olfactory neuroblastoma / rat
  •  go-up   go-down


64. Aboziada MA, Eisbruch A: Esthesioneuroblastoma: the role of post-operative irradiation after complete surgical resection. J Egypt Natl Canc Inst; 2010 Jun;22(2):143-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Esthesioneuroblastoma: the role of post-operative irradiation after complete surgical resection.
  • BACKGROUND: Esthesioneuroblastoma is a rare tumor and this retrospective report was done to evaluate the role of post-operative radiotherapy after complete surgical resection of the tumor.
  • PATIENTS AND METHODS: Twenty nine patients with Esthesioneuroblastoma of Kadish stages A (1), B (19), C (6) and unknown (3) were retrospectively identified through the hospital data-base, patients charts, imaging studies and computerized notes between 1995 to 2007 at Department of Radiation Oncology, University of Michigan, U.S.A.
  • Disease free cumulative survival rate at 5-years was 88% for the group which received post-operative radiotherapy compared with 35% for the group which did not receive (p=0.02).
  • CONCLUSION: Adjuvant radiotherapy to the tumor bed after craniofacial resection improves significantly local control and disease free survival.
  • KEY WORDS: Esthesioneuroblastoma - Radiotherapy - Surgery.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21860471.001).
  • [ISSN] 1110-0362
  • [Journal-full-title] Journal of the Egyptian National Cancer Institute
  • [ISO-abbreviation] J Egypt Natl Canc Inst
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Egypt
  •  go-up   go-down


65. Kiprian D: [Strategy of combined treatment in patient with cancer of paranasal sinuses]. Otolaryngol Pol; 2007;61(4):527-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Strategy of combined treatment in patient with cancer of paranasal sinuses].
  • In 2003, in Poland there were 132 new patients diagnosed for this disease.
  • There is a very rare neoplasm as a olfactory neuroblastoma in this localization.
  • Cancer of the paranasal sinuses infiltrates only locoregionally.
  • The treatment of cancers of paranasal sinuses is always surgery with adjuvant irradiation.
  • [MeSH-major] Paranasal Sinus Neoplasms / diagnosis. Paranasal Sinus Neoplasms / therapy
  • [MeSH-minor] Combined Modality Therapy. Humans. Incidence. Neoplasm Staging. Radiotherapy, Conformal. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18260245.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Poland
  • [Number-of-references] 5
  •  go-up   go-down


66. Díez-Villalba R, González-Ruiz M, Izquierdo-Vázquez C, Molina-Quirós C, Colmenero-Ruiz M, Ramos-Amador A, Jordano-Luna L, Mora-de-Oñate J, Sanz-Fernández R: [Ophthalmic presentation of two cases of esthesioneuroblastoma]. Arch Soc Esp Oftalmol; 2008 May;83(5):317-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Ophthalmic presentation of two cases of esthesioneuroblastoma].
  • [Transliterated title] Debut oftalmológico de dos casos de estesioneuroblastoma.
  • PURPOSE/METHOD: To report the ophthalmologic presentation of two cases of esthesioneuroblastoma (ENB).
  • A paranasal sinus mass was biopsied in one case and a nasal mass biopsied in the other.
  • ENB is a rare malignant tumour and its presentation with ophthalmologic symptoms and signs is very infrequent.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / complications. Nasal Cavity. Nose Neoplasms / complications

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18464181.001).
  • [ISSN] 0365-6691
  • [Journal-full-title] Archivos de la Sociedad Española de Oftalmología
  • [ISO-abbreviation] Arch Soc Esp Oftalmol
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


67. Myssiorek D, Tronco G: 111Indium pentetreotide imaging in the evaluation of head and neck tumors. Laryngoscope; 2005 Oct;115(10):1707-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES/HYPOTHESIS: Peptide receptor imaging with Indium pentetreotide is useful in the diagnosis of diffuse neuroendocrine system tumors (DNEST) of the head and neck.
  • CONCLUSIONS: Indium pentetreotide scintigraphy is accurate in determining the presence of paragangliomas, carcinoid tumors, esthesioneuroblastomas, small cell neuroendocrine tumors, andmetastases.

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16222183.001).
  • [ISSN] 0023-852X
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Indium Radioisotopes; 0 / Radiopharmaceuticals; 0 / Receptors, Somatostatin; 51110-01-1 / Somatostatin; G083B71P98 / pentetreotide
  •  go-up   go-down


68. Yao Q, Yue CL, Lü ZC, Han YD, Liu HG: [Olfactory neuroblastoma with unusual structures: a clinical pathologic study]. Zhonghua Bing Li Xue Za Zhi; 2009 Mar;38(3):163-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Olfactory neuroblastoma with unusual structures: a clinical pathologic study].
  • OBJECTIVE: To investigate unusual pathological features of olfactory neuroblastoma (ONB) and its correlation with the clinical prognosis.
  • METHODS: Totally 40 cases of ONB were studied using histology and immunohistochemistry techniques.
  • All the cases of ONB were graded according to Hyams Grading system.
  • RESULTS: ONB consisted of small round tumor cells growing in nests or lobules separated by fibrovascular septa.
  • In addition, 3 cases showed an in-situ form with invasion of tumor into olfactory epithelium, and there was exogenous papillary proliferation seen in 2 cases.
  • CONCLUSIONS: Unusual pathological structures including epithelial structures, in-situ invasion of tumor tissue into the involving olfactory epithelium and exogenous papillary proliferation can be found in ONB, suggesting that ONB may originate from the undifferentiated basal cells of olfactory epithelium, through bipotential differentiation.
  • The presence of tumor necrosis in ONB is a poor prognostic indicator while the presence of mucous cells suggests a good prognosis.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / pathology. Nasal Cavity. Nose Neoplasms / pathology. Olfactory Mucosa / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Chromogranin A / metabolism. Female. Follow-Up Studies. Humans. Lung Neoplasms / secondary. Lymphatic Metastasis. Male. Necrosis. Neoplasm Invasiveness. Neoplasm Recurrence, Local. Phosphopyruvate Hydratase / metabolism. Survival Rate. Synaptophysin / metabolism. Young Adult

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19575850.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Chromogranin A; 0 / Synaptophysin; EC 4.2.1.11 / Phosphopyruvate Hydratase
  •  go-up   go-down


69. Ueno H, Kobayashi Y, Yamada K: Olfactory esthesioneuroblastoma treated with orthovoltage radiotherapy in a dog. Aust Vet J; 2007 Jul;85(7):271-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Olfactory esthesioneuroblastoma treated with orthovoltage radiotherapy in a dog.
  • On computed tomography examination, a mass was demonstrated in the nasal cavity.
  • Open biopsy of the mass was performed and a diagnosis of olfactory esthesioneuroblastoma was made on histological examination.
  • [MeSH-major] Dog Diseases / radiotherapy. Esthesioneuroblastoma, Olfactory / veterinary
  • [MeSH-minor] Animals. Dogs. Dose-Response Relationship, Radiation. Female. Neoplasm Recurrence, Local. Radiotherapy Dosage. X-Rays

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17615040.001).
  • [ISSN] 0005-0423
  • [Journal-full-title] Australian veterinary journal
  • [ISO-abbreviation] Aust. Vet. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


70. Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Buencamino R, Fang S, Barani IJ, Parsa AT: Posttreatment prognosis of patients with esthesioneuroblastoma. J Neurosurg; 2010 Aug;113(2):340-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Posttreatment prognosis of patients with esthesioneuroblastoma.
  • OBJECT: There is no Class I evidence to guide the appropriate management of esthesioneuroblastoma (EN).
  • [MeSH-major] Esthesioneuroblastoma, Olfactory. Nasal Cavity. Nose Neoplasms

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neurosurg. 2012 Dec;117(6):1206-7 [23020767.001]
  • (PMID = 20345216.001).
  • [ISSN] 1933-0693
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Grant] United States / Howard Hughes Medical Institute / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
  • [Publication-country] United States
  • [Number-of-references] 222
  •  go-up   go-down


71. Sharma NK, Pandey J, Gupta N, Jain RK: Growth and physiological response of Arthrobacter protophormiae RKJ100 toward higher concentrations of o-nitrobenzoate and p-hydroxybenzoate. FEMS Microbiol Lett; 2007 Jun;271(1):65-70
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the present study we have characterized the growth response and physiological changes (adaptations) of a Gram-positive bacterium, Arthrobacter protophormiae RKJ100, toward the higher concentrations of two aromatic compounds, viz. o-nitrobenzoate (ONB) and p-hydroxybenzoate (PHB).
  • Arthrobacter protophormiae RKJ100 could utilize 30 mM ONB and 50 mM PHB as sole sources of carbon and energy.
  • It was capable of growth on higher concentrations of ONB (up to 200 mM) and PHB (up to 150 mM) when the cells were pre-exposed to lower concentrations of these compounds.
  • In addition, Bacterial Adhesion To Hydrocarbon (BATH) assay and scanning electron microscopy showed substantial increase in cell surface hydrophobicity and decrease in cell size of A. protophormiae RKJ100 when grown on ONB and PHB as compared to succinate-grown cells.

  • Hazardous Substances Data Bank. SUCCINIC ACID .
  • Hazardous Substances Data Bank. CARBON .
  • Hazardous Substances Data Bank. 4-HYDROXYBENZOIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17391368.001).
  • [ISSN] 0378-1097
  • [Journal-full-title] FEMS microbiology letters
  • [ISO-abbreviation] FEMS Microbiol. Lett.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / 2-nitrobenzoate; 0 / Fatty Acids; 0 / Nitrobenzoates; 0 / Parabens; 7440-44-0 / Carbon; AB6MNQ6J6L / Succinic Acid; JG8Z55Y12H / 4-hydroxybenzoic acid
  •  go-up   go-down


72. Sołtys J, Pietniczka-Załeska M, Młyńczyk-Budzynowska K, Majkowski J: [Neoplasms of paranasal sinuses in material of ENT Department MSS Hospital in Warsaw between 2006-2007]. Otolaryngol Pol; 2008;62(4):451-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Neoplasms of paranasal sinuses in material of ENT Department MSS Hospital in Warsaw between 2006-2007].
  • Tumors of paranasal sinuses present a small percent of tumors detected in the region of head and neck 3-4% and they present a fraction of a percent of tumors in general /0.16%/.
  • MATERIAL: In the years 2004 and 2005, the National Register of Neoplasms recorded 120 and 132 cases of malignant tumors of paranasal sinuses, respectively.
  • Between 2006-2007 we treated 15 patients with tumors of paranasal sinuses underwent treatment at the ENT department of the MiEdzyleski Szpital Specjalistyczny in Warsaw.
  • THE RESULTS: We detected the following:--benign neoplasms: 2 cases of angiofibroma, 3 cases of inverted papilloma;--malignant tumors: 4 cases of Ca planoepitheliale, 1 instance of adenocarcinoma, 1 instance of Ca anaplasticum, 1--melanoma, 1--esthesioneuroblastoma, 1--lymphoma malignum, 1--metastatic tumor.
  • THE CONCLUSIONS: at the moment of the admission for treatment at the ENT department, the advancement stage of tumor T3/T4, from the first signs until the proper diagnosis was that marked with the passage of eight months.
  • Ca planoepitheliale is the most common type of malignant tumors of paranasal sinuses.
  • It is only good cooperation between the surgeon and the pathologist which makes it possible to put the proper diagnosis.
  • [MeSH-major] Carcinoma / diagnosis. Nose Neoplasms / diagnosis. Paranasal Sinus Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Hospitals, Public. Humans. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Otorhinolaryngologic Surgical Procedures / methods. Poland. Retrospective Studies. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18837222.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


73. Wang CC, Chen YL, Hsu YS, Jung SM, Hao SP: Transcranial resection of olfactory neuroblastoma. Skull Base; 2005 Aug;15(3):163-71; discussion 171
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transcranial resection of olfactory neuroblastoma.
  • From February 1995 to August 2004 at Chang Gung Memorial Hospital and Chang Gung University, eight patients with an olfactory neuroblastoma underwent transcranial resection alone.
  • The transcranial surgical technique consisted of a bicoronal incision, followed by a standard frontal craniotomy with or without a separated orbital bar osteotomy.
  • With thorough knowledge of the basic topographic anatomy of the anterior cranial base, transcranial resection can provide adequate surgical exposure to facilitate oncologically sound resection and to execute reliable skull base reconstruction in selected patients with an olfactory neuroblastoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Otolaryngol Allied Sci. 1999 Sep;24(5):457-61 [10542931.001]
  • [Cites] Laryngoscope. 1990 Nov;100(11):1199-201 [2233084.001]
  • [Cites] Arch Otolaryngol. 1977 Sep;103(9):514-7 [332133.001]
  • [Cites] Cancer. 1979 Sep;44(3):1087-94 [383268.001]
  • [Cites] Cancer. 1995 Jul 1;76(1):4-19 [8630875.001]
  • [Cites] Neurosurgery. 1996 Mar;38(3):471-9; discussion 479-80 [8837798.001]
  • [Cites] J Otolaryngol. 1997 Feb;26(1):1-7 [9055166.001]
  • [Cites] Anticancer Res. 1997 Jul-Aug;17(4A):2683-706 [9252701.001]
  • [Cites] Am J Surg. 1997 Nov;174(5):565-8 [9374239.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1997 Dec;123(12):1312-7 [9413360.001]
  • [Cites] Head Neck. 1999 Jan;21(1):12-20 [9890346.001]
  • [Cites] Laryngoscope. 1999 Jan;109(1):153-60 [9917058.001]
  • [Cites] J Formos Med Assoc. 2000 Dec;99(12):914-9 [11155744.001]
  • [Cites] Otolaryngol Head Neck Surg. 2001 Mar;124(3):292-6 [11240994.001]
  • [Cites] Am J Rhinol. 2001 Jul-Aug;15(4):271-9 [11554661.001]
  • [Cites] Laryngoscope. 2002 Sep;112(9):1691-5 [12352688.001]
  • [Cites] Cancer. 1976 Mar;37(3):1571-6 [1260676.001]
  • [Cites] Laryngoscope. 2003 Mar;113(3):502-7 [12616204.001]
  • [Cites] Otolaryngol Head Neck Surg. 2003 Apr;128(4):571-5 [12707663.001]
  • [Cites] Head Neck. 1992 Nov-Dec;14(6):477-82 [1468921.001]
  • [Cites] Laryngoscope. 1992 Aug;102(8):843-9 [1495347.001]
  • [Cites] J Neurosurg. 1992 Feb;76(2):198-206 [1730948.001]
  • [Cites] Laryngoscope. 2000 Apr;110(4):635-40 [10764010.001]
  • (PMID = 16175226.001).
  • [ISSN] 1531-5010
  • [Journal-full-title] Skull base : official journal of North American Skull Base Society ... [et al.]
  • [ISO-abbreviation] Skull Base
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1214702
  •  go-up   go-down


74. McLean JN, Nunley SR, Klass C, Moore C, Müller S, Johnstone PA: Combined modality therapy of esthesioneuroblastoma. Otolaryngol Head Neck Surg; 2007 Jun;136(6):998-1002
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined modality therapy of esthesioneuroblastoma.
  • OBJECTIVE: Esthesioneuroblastoma (ENB) is a rare tumor of the olfactory epithelium.
  • The 5-year crude disease-free survival rate was 59% and the 5-year actuarial disease-free survival rate was 62% (CI, 28 and 83, respectively).
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / therapy. Nasal Cavity. Nose Neoplasms / therapy
  • [MeSH-minor] Biomarkers, Tumor / analysis. Combined Modality Therapy. Disease Progression. Disease-Free Survival. Follow-Up Studies. Humans. Neoplasm Staging. Olfactory Mucosa / pathology. Retrospective Studies

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17547995.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Grant] United States / NIMHD NIH HHS / MD / 5P60-MD000525
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


75. Shapiro NL, Bhattacharyya N: Staging and survival for sinus cancer in the pediatric population. Int J Pediatr Otorhinolaryngol; 2009 Nov;73(11):1568-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Staging and survival for sinus cancer in the pediatric population.
  • OBJECTIVE: To determine histology, staging, and survival for pediatric sinus cancer.
  • METHODS: Cases of pediatric sinus cancer (maxillary, ethmoid, and frontal/sphenoid) were extracted from the Surveillance, Epidemiology, and End Results database (1988-2005).
  • RESULTS: 63 pediatric sinus cancers were identified (38 maxillary sinus, 19 ethmoid sinus, and 6 frontal/sphenoid sinus) with a mean age at diagnosis of 10.5 years and a 1:1 male to female ratio.
  • After exclusion of 11 lymphomas (17.5%), rhabdomyosarcoma was the most commonly encountered malignancy (52.0%) followed by sarcoma (17.3%) and olfactory neuroblastoma (13.5%).
  • 41.4% and 42.1% of maxillary sinus and ethmoid sinus tumors presented as T4 tumors, respectively.
  • Median survival for pediatric sinus rhabdomyosarcoma cases was estimated at 33.0 months.
  • CONCLUSIONS: Pediatric sinus malignancy commonly presents with advanced stage, and rhabdomyosarcoma is the most commonly encountered histology.
  • Due to the rarity of pediatric sinus cancer, survival estimates are difficult to obtain.
  • [MeSH-major] Paranasal Sinus Neoplasms / mortality. Paranasal Sinus Neoplasms / pathology. Rhabdomyosarcoma / mortality. Rhabdomyosarcoma / pathology
  • [MeSH-minor] Child. Female. Humans. Male. Neoplasm Staging. SEER Program. Survival Analysis

  • Genetic Alliance. consumer health - Sinus cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19720405.001).
  • [ISSN] 1872-8464
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


76. Koo BK, An JH, Jeon KH, Choi SH, Cho YM, Jang HC, Chung JH, Lee CH, Lim S: Two cases of ectopic adrenocorticotropic hormone syndrome with olfactory neuroblastoma and literature review. Endocr J; 2008 Jul;55(3):469-75
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Two cases of ectopic adrenocorticotropic hormone syndrome with olfactory neuroblastoma and literature review.
  • Olfactory neuroblastomas are rare, slow-growing malignant tumors, usually diagnosed at advanced stages.
  • Ectopic adrenocorticotropic hormone (ACTH) syndrome caused by an olfactory neuroblastoma is extremely rare.
  • We reported two Korean women who suffered from ectopic ACTH syndrome (EAS) caused by olfactory neuroblastomas.
  • The first patient was a 66-year-old woman who had been diagnosed as olfactory neuroblastoma and refused the management two years before and the second patient was a 37-year-old woman on chemotherapy for olfactory neuroblastoma.
  • [MeSH-major] ACTH Syndrome, Ectopic / radiography. Esthesioneuroblastoma, Olfactory / secretion. Nasal Cavity / radiography. Nose Neoplasms / secretion

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • Hazardous Substances Data Bank. HYDROCORTISONE .
  • Hazardous Substances Data Bank. Corticotropin .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18469486.001).
  • [ISSN] 1348-4540
  • [Journal-full-title] Endocrine journal
  • [ISO-abbreviation] Endocr. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 9002-60-2 / Adrenocorticotropic Hormone; WI4X0X7BPJ / Hydrocortisone
  • [Number-of-references] 36
  •  go-up   go-down


77. Ma R: [Analysis of diagnosis and treatment of 6 cases with esthesioneuroblastoma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Apr;23(8):352-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Analysis of diagnosis and treatment of 6 cases with esthesioneuroblastoma].
  • OBJECTIVE: To explore the diagnosis and treatment and prognosis of esthesioneuroblastoma.
  • METHOD: The clinical data of 6 cases with esthesioneuroblastoma were analyzed retrospectively.
  • The key to improving the survival rate of the disease is early accurate diagnosis and combined treatment.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / diagnosis. Esthesioneuroblastoma, Olfactory / therapy

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19685713.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


78. Sahai-Srivastava S, Subhani D: Adverse effect profile of lidocaine injections for occipital nerve block in occipital neuralgia. J Headache Pain; 2010 Dec;11(6):519-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To determine whether there are differences in the adverse effect profile between 1, 2 and 5% Lidocaine when used for occipital nerve blocks (ONB) in patients with occipital neuralgia.
  • Retrospective chart analysis of all ONB was performed at our headache clinic during a 6-year period on occipital neuralgia patients.
  • 89 consecutive patients with occipital neuralgia underwent a total of 315 ONB.
  • ONB is a safe procedure with 1% Lidocaine; however, caution should be exerted with 5% in elderly patients, 70 or older, especially when administering bilateral injections.

  • MedlinePlus Health Information. consumer health - Headache.
  • MedlinePlus Health Information. consumer health - Trigeminal Neuralgia.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. LIDOCAINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Headache. 1987 Apr;27(4):201-5 [3036748.001]
  • [Cites] Postgrad Med. 1986 Sep 15;80(4):159-60 [3763512.001]
  • [Cites] Clin Neurol Neurosurg. 1992;94(4):297-301 [1335856.001]
  • [Cites] Reg Anesth Pain Med. 1998 Jan-Feb;23(1):96-100 [9552786.001]
  • [Cites] Plast Reconstr Surg. 2005 May;115(6):1752-8; discussion 1759-60 [15861086.001]
  • [Cites] Cephalalgia. 2005 Sep;25(9):704-8 [16109052.001]
  • [Cites] Pain. 2005 Nov;118(1-2):92-6 [16202532.001]
  • [Cites] Pain. 2006 May;122(1-2):126-9 [16527404.001]
  • [Cites] Pain Pract. 2006 Dec;6(4):278-84 [17129309.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):415-7 [17682008.001]
  • [Cites] Headache. 2009 Nov-Dec;49(10):1521-33 [19674126.001]
  • [Cites] Clin Exp Rheumatol. 2000 Mar-Apr;18(2 Suppl 19):S59-64 [10824289.001]
  • [Cites] Headache. 2001 Oct;41(9):902-4 [11703480.001]
  • [Cites] Cephalalgia. 2004;24 Suppl 1:9-160 [14979299.001]
  • [Cites] Am Fam Physician. 1986 Jan;33(1):183-6 [3942046.001]
  • [Cites] Cephalalgia. 1992 Feb;12(1):9-13 [1559261.001]
  • (PMID = 20665065.001).
  • [ISSN] 1129-2377
  • [Journal-full-title] The journal of headache and pain
  • [ISO-abbreviation] J Headache Pain
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 98PI200987 / Lidocaine
  • [Other-IDs] NLM/ PMC3476234
  •  go-up   go-down


79. Nabili V, St John M, Cohan P, Lufkin R, Bhuta S, Abemayor E: Radiology quiz case 1. Catecholamine-secreting olfactory neuroblastoma (OFN). Arch Otolaryngol Head Neck Surg; 2006 Mar;132(3):342, 344-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiology quiz case 1. Catecholamine-secreting olfactory neuroblastoma (OFN).
  • [MeSH-major] Catecholamines / secretion. Esthesioneuroblastoma, Olfactory / diagnosis. Nasal Cavity. Nose Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Neuroblastoma.
  • Genetic Alliance. consumer health - Neuroblastoma 1.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16549757.001).
  • [ISSN] 0886-4470
  • [Journal-full-title] Archives of otolaryngology--head & neck surgery
  • [ISO-abbreviation] Arch. Otolaryngol. Head Neck Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Catecholamines
  •  go-up   go-down


80. Nishimura H, Ogino T, Kawashima M, Nihei K, Arahira S, Onozawa M, Katsuta S, Nishio T: Proton-beam therapy for olfactory neuroblastoma. Int J Radiat Oncol Biol Phys; 2007 Jul 1;68(3):758-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Proton-beam therapy for olfactory neuroblastoma.
  • PURPOSE: To analyze the feasibility and efficacy of proton-beam therapy (PBT) for olfactory neuroblastoma (ONB) as a definitive treatment, by reviewing our preliminary experience.
  • Olfactory neuroblastoma is a rare disease, and a standard treatment strategy has not been established.
  • Radiation therapy for ONB is challenging because of the proximity of ONBs to critical organs.
  • METHODS AND MATERIALS: A retrospective review was performed on 14 patients who underwent PBT for ONB as definitive treatment at the National Cancer Center Hospital East (Kashiwa, Chiba, Japan) from November 1999 to February 2005.
  • One patient died from disseminated disease.
  • Liquorrhea was observed in one patient with Kadish's stage C disease (widely destroying the skull base).
  • CONCLUSIONS: Our preliminary results of PBT for ONB achieved excellent local control and survival outcomes without serious adverse effects.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / radiotherapy. Nasal Cavity. Neoplasm Recurrence, Local / prevention & control. Nose Neoplasms / radiotherapy. Protons / therapeutic use
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Disease-Free Survival. Female. Humans. Male. Middle Aged. Retrospective Studies

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17398027.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Protons
  •  go-up   go-down


81. Zeng M, Cui Y, Wu C: [Expression of SSTR2 and P-STAT3 in human olfactory neuroblastoma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug;24(15):690-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression of SSTR2 and P-STAT3 in human olfactory neuroblastoma].
  • OBJECTIVE: To detect the expression and relationship between somatostatin receptor 2 (SSTR2) and phosphorylated STAT3 (P-STAT3) in human olfactory neuroblastoma (ONB) and adjacent normal olfactory nerve tissue.
  • METHOD: Immunohistochemical (IHC) staining was used to detect the expression of SSTR2 and P-STAT3 in tumor and adjacent normal olfactory nerve tissue from 11 ONB patients.
  • CONCLUSION: Lower expression of SSTR2 and activation of STAT3 in ONB cells might contribute to the development of ONB.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / metabolism. Nose Neoplasms / metabolism. Receptors, Somatostatin / metabolism. STAT3 Transcription Factor / metabolism

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20942237.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Receptors, Somatostatin; 0 / STAT3 Transcription Factor; 0 / STAT3 protein, human; 0 / somatostatin receptor 2
  •  go-up   go-down


82. Villaret AB, Yakirevitch A, Bizzoni A, Bosio R, Bignami M, Pistochini A, Battaglia P, Castelnuovo P, Nicolai P: Endoscopic transnasal craniectomy in the management of selected sinonasal malignancies. Am J Rhinol Allergy; 2010 Jan-Feb;24(1):60-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Because of a better understanding of the anatomy from an endoscopic perspective, the acquisition of surgical experience, and concomitant technological advances, endoscopic resection of the anterior skull base (ASB) and overlying dura has now become a reality, opening new possibilities in the management of sinonasal malignancies.
  • METHODS: From 2004, 62 patients underwent ETC at two referral hospitals, which extended anteroposteriorly from the frontal sinus to planum sphenoidale and laterolaterally from the nasal septum to the lamina papyracea (unilateral resection, n = 28; 45%) or from papyracea to papyracea (bilateral resection, n = 34; 55%).
  • RESULTS: The most frequent histotypes were adenocarcinoma (58%) and olfactory neuroblastoma (22%).
  • After a mean follow-up of 17.5 months (range, 1-54 months), 58 (94%) patients had no evidence of disease.
  • [MeSH-major] Adenocarcinoma / surgery. Cerebrospinal Fluid Rhinorrhea / etiology. Craniotomy / adverse effects. Endoscopy / adverse effects. Neuroblastoma / surgery. Nose Neoplasms / surgery. Postoperative Complications
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Disease-Free Survival. Female. Humans. Male. Middle Aged. Neoplasm Staging. Skull Base / surgery


83. Parker VJ, Morrison JA, Yaeger MJ: Olfactory neuroblastoma in a cat. J Feline Med Surg; 2010 Nov;12(11):867-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Olfactory neuroblastoma in a cat.
  • Physical examination suggested upper airway disease.
  • Computed tomography revealed the presence of a nasopharyngeal mass.
  • Biopsies obtained via rhinoscopy led to a diagnosis of olfactory neuroblastoma.
  • CLINICAL CHALLENGES: Olfactory neuroblastoma (or esthesioneuroblastoma) is a rare malignant neoplasm that arises from olfactory neuroepithelium.
  • Clinical signs are variable, and diagnosis may prove challenging as this tumor, which is a differential for spontaneous intranasal tumors in cats, may be mistaken for poorly differentiated carcinomas or round cell tumors.
  • Given its rarity, treatment options for this neoplasm have not been thoroughly evaluated and there is no standard treatment protocol.
  • [MeSH-major] Cat Diseases / diagnosis. Esthesioneuroblastoma, Olfactory / veterinary. Nasal Cavity. Nose Neoplasms / veterinary
  • [MeSH-minor] Animals. Cats. Diagnosis, Differential. Male

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 ISFM and AAFP. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 20974404.001).
  • [ISSN] 1532-2750
  • [Journal-full-title] Journal of feline medicine and surgery
  • [ISO-abbreviation] J. Feline Med. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


84. Mrad K, Mansouri D, Driss M, Sassi S, Abbes I, Ben Ayed F, Ben Romdhane K: Esthesioneuroblastoma metastatic to the breast in a young woman. Acta Cytol; 2005 Jul-Aug;49(4):427-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Esthesioneuroblastoma metastatic to the breast in a young woman.
  • We report an unusual breast metastasis originating in an olfactory neuroblastoma.
  • CASE: A breast metastasis from esthesioneuroblastoma occurred in a 20-year-old woman 2 years after the onset of the disease.
  • Because we were unaware of the past history at the time of the cytologic analysis, a definitive diagnosis was made only after pathologic study.
  • CONCLUSION: Esthesioneuroblastoma metastatic to the breast must be considered in the differential diagnosis of breast metastases.
  • Fine needle aspiration, in conjunction with clinical information, can be effective in the diagnosis of esthesioneuroblastoma metastatic to the breast.
  • [MeSH-major] Breast Neoplasms / diagnosis. Esthesioneuroblastoma, Olfactory / diagnosis. Nasal Cavity / pathology. Nose Neoplasms / diagnosis


85. Levine PA: Would Dr. Ogura approve of endoscopic resection of esthesioneuroblastomas? An analysis of endoscopic resection data versus that of craniofacial resection. Laryngoscope; 2009 Jan;119(1):3-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Would Dr. Ogura approve of endoscopic resection of esthesioneuroblastomas? An analysis of endoscopic resection data versus that of craniofacial resection.
  • [MeSH-major] Craniotomy / methods. Endoscopy. Esthesioneuroblastoma, Olfactory / surgery. Facial Bones / surgery. Nasal Cavity / surgery. Nose Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19117289.001).
  • [ISSN] 1531-4995
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Addresses
  • [Publication-country] United States
  •  go-up   go-down


86. Capelle L, Krawitz H: Esthesioneuroblastoma: a case report of diffuse subdural recurrence and review of recently published studies. J Med Imaging Radiat Oncol; 2008 Feb;52(1):85-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Esthesioneuroblastoma: a case report of diffuse subdural recurrence and review of recently published studies.
  • Esthesioneuroblastoma is a rare malignancy arising from the olfactory epithelium.
  • We present a case history of a 75-year-old man who presented with a Kadish stage C esthesioneuroblastoma and underwent craniofacial surgery and adjuvant radiotherapy.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / diagnosis. Meningeal Neoplasms / secondary. Nasal Cavity / pathology. Nasal Cavity / radiography. Nose Neoplasms / diagnosis. Spinal Neoplasms / secondary

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18373833.001).
  • [ISSN] 1754-9477
  • [Journal-full-title] Journal of medical imaging and radiation oncology
  • [ISO-abbreviation] J Med Imaging Radiat Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Australia
  • [Number-of-references] 26
  •  go-up   go-down


87. Dave SP, Bared A, Casiano RR: Surgical outcomes and safety of transnasal endoscopic resection for anterior skull tumors. Otolaryngol Head Neck Surg; 2007 Jun;136(6):920-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were 17 malignant and two benign lesions.
  • Olfactory neuroblastoma was the most common pathology, occurring in 53 percent of patients.
  • One patient recurred locally, resulting in an overall local control rate of 94.7 percent for all neoplasms and 94.1 percent for malignant disease.
  • Overall, there were 16 complications, but only two of these, an orbital hematoma and a frontal lobe abscess, were considered major complications directly attributable to surgery.
  • [MeSH-major] Carcinoma / surgery. Cranial Fossa, Anterior / surgery. Endoscopy. Esthesioneuroblastoma, Olfactory / surgery. Hemangiopericytoma / surgery. Meningeal Neoplasms / surgery. Meningioma / surgery. Nose Neoplasms / surgery. Postoperative Complications / etiology. Skull Base Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Chemotherapy, Adjuvant. Combined Modality Therapy. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Staging. Radiotherapy, Adjuvant. Reoperation. Retrospective Studies. Survival Rate

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17547980.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


88. Lund V, Howard DJ, Wei WI: Endoscopic resection of malignant tumors of the nose and sinuses. Am J Rhinol; 2007 Jan-Feb;21(1):89-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic resection of malignant tumors of the nose and sinuses.
  • However, the rarity and long natural history of malignant tumors make it difficult to accrue cohorts comparable with the established gold standard of craniofacial resection.
  • METHODS: In this prospective cohort study, after histological confirmation and a staging imaging protocol, patients deemed suitable were offered the option of an entirely endoscopic resection as an alternative to craniofacial resection.
  • A wide range of pathologies included 15 cases of adenocarcinoma, 11 malignant melanomas, and 11 olfactory neuroblastomas.
  • Thirty-six patients are alive and well, 7 patients have residual disease, 4 patients are dead of disease, and 2 patients have died of intercurrent disease.
  • [MeSH-major] Endoscopy / methods. Nose Neoplasms / surgery. Paranasal Sinus Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Disease-Free Survival. Female. Follow-Up Studies. Humans. Length of Stay. Magnetic Resonance Imaging. Male. Middle Aged. Prospective Studies. Survival Rate. Time Factors. Tomography, X-Ray Computed. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17283568.001).
  • [ISSN] 1050-6586
  • [Journal-full-title] American journal of rhinology
  • [ISO-abbreviation] Am J Rhinol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


89. Liao H, Hua QQ, Wu ZY: [Maxillary swing approach in the management of tumors in the central and lateral cranial base]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Apr;41(4):276-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Among them, five suffered from chordoma, two had rhabdomyosarcoma, two had squamous cell carcinoma, one had malignant fibrous histiocytoma, one had malignant melanoma, one had esthesioneuroblastoma, one had invaded hypophysoma, two had schwannoma, one had pleomorphic adenoma, and one had angiofibroma.
  • Of the 12 malignant tumors, the 1-and 2-year survival rate were 91.67% and 72.92%, respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16848177.001).
  • [ISSN] 1673-0860
  • [Journal-full-title] Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
  • [ISO-abbreviation] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] China
  •  go-up   go-down


90. Papoutsi Z, Kassi E, Halabalaki M, Mitakou S, Moutsatsou P: Evaluation of estrogenic/antiestrogenic activity of Onobrychis ebenoides extract - interaction with estrogen receptor subtypes ERalpha and ERbeta. Toxicol In Vitro; 2007 Apr;21(3):364-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To investigate the molecular mechanisms that underly the beneficial effect of O. ebenoides (Onb) on bone loss, we studied its potential to activate ER subtypes (ERalpha and ERbeta) on transiently transfected HeLa cells with HO-hERalpha or pSG5-hERbeta and 3xERE-TATA-Luc expression vectors.
  • (1) Onb extract displayed a significant estrogenic activity on both ERalpha and ERbeta subtypes. (2) It exhibited direct action on osteoblasts by inducing mineralization. (3) It showed estrogenic activity in MCF7 cells.
  • These findings suggest that the beneficial effect of Onb extract on bone loss is mediated through an estrogen-like action via activation of ERalpha-ERE and ERbeta-ERE pathways and via direct action on the mineralization process of osteoblasts.

  • Hazardous Substances Data Bank. FULVESTRANT .
  • Hazardous Substances Data Bank. ESTRADIOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17092687.001).
  • [ISSN] 0887-2333
  • [Journal-full-title] Toxicology in vitro : an international journal published in association with BIBRA
  • [ISO-abbreviation] Toxicol In Vitro
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Estrogen Antagonists; 0 / Estrogen Receptor alpha; 0 / Estrogen Receptor beta; 0 / IGFBP3 protein, human; 0 / Insulin-Like Growth Factor Binding Protein 3; 0 / Insulin-Like Growth Factor Binding Proteins; 0 / Phytoestrogens; 0 / Plant Extracts; 22X328QOC4 / fulvestrant; 4TI98Z838E / Estradiol; EC 1.13.12.- / Luciferases
  •  go-up   go-down


91. Zhou SH, Ruan LX, Li H: [Diabetes insipidus caused by olfactory neuroblastoma: a case report]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Jun;41(6):465-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diabetes insipidus caused by olfactory neuroblastoma: a case report].
  • [MeSH-major] Diabetes Insipidus / etiology. Esthesioneuroblastoma, Olfactory / complications


92. Daly ME, Chen AM, Bucci MK, El-Sayed I, Xia P, Kaplan MJ, Eisele DW: Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys; 2007 Jan 1;67(1):151-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses.
  • PURPOSE: To report the clinical outcome of patients treated with intensity-modulated radiation therapy (IMRT) for malignancies of the nasal cavity and paranasal sinuses.
  • The primary sites were: 13 ethmoid sinus, 10 maxillary sinus, 7 nasal cavity, and 6 other.
  • Histology was: 12 squamous cell, 7 esthesioneuroblastoma, 5 adenoid cystic, 5 undifferentiated, 5 adenocarcinoma, and 2 other.
  • The 5-year rates of disease-free and overall survival were 55% and 45%, respectively.
  • CONCLUSION: Although IMRT for malignancies of the sinonasal region does not appear to lead to significant improvements in disease control, the low incidence of complications is encouraging.
  • [MeSH-major] Nose Neoplasms / radiotherapy. Paranasal Sinus Neoplasms / radiotherapy. Radiotherapy, Intensity-Modulated
  • [MeSH-minor] Adenocarcinoma / radiotherapy. Adenocarcinoma / secondary. Adult. Aged. Aged, 80 and over. Carcinoma, Adenoid Cystic / radiotherapy. Carcinoma, Adenoid Cystic / secondary. Carcinoma, Squamous Cell / radiotherapy. Carcinoma, Squamous Cell / secondary. Esthesioneuroblastoma, Olfactory / radiotherapy. Esthesioneuroblastoma, Olfactory / secondary. Female. Humans. Male. Middle Aged. Nasal Cavity. Neoplasm Staging. Radiation Injuries / etiology. Radiotherapy Dosage

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17189068.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


93. Madani I, Bonte K, Vakaet L, Boterberg T, De Neve W: Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys; 2009 Feb 1;73(2):424-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The tumor histologic type was adenocarcinoma in 54, squamous cell carcinoma in 17, esthesioneuroblastoma in 9, and adenoid cystic carcinoma in 4.
  • The tumors were located in the ethmoid sinus in 47, maxillary sinus in 19, nasal cavity in 16, and multiple sites in 2.
  • The 5-year local control, overall survival, disease-specific survival, disease-free survival, and freedom from distant metastasis rate was 70.7%, 58.5%, 67%, 59.3%, and 82.2%, respectively.
  • [MeSH-major] Nose Neoplasms / radiotherapy. Paranasal Sinus Neoplasms / radiotherapy. Radiotherapy, Intensity-Modulated
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Disease-Free Survival. Female. Follow-Up Studies. Hospitals, University. Humans. Male. Middle Aged. Multivariate Analysis. Neoplasm Recurrence, Local / mortality. Neoplasm Recurrence, Local / radiotherapy. Radiotherapy Dosage. Survival Rate. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18755554.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


94. Koschny R, Holland H, Sykora J, Erdal H, Krupp W, Bauer M, Bockmuehl U, Ahnert P, Meixensberger J, Stremmel W, Walczak H, Ganten TM: Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis. J Neurooncol; 2010 Apr;97(2):171-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis.
  • Using primary esthesioneuroblastoma cells we analyzed the anti-tumor potential and the mechanism employed by Bortezomib in combination with TRAIL for the treatment of this rare but aggressive tumor.
  • Cells were treated with TRAIL, Bortezomib, and a combination thereof, and apoptosis induction was quantified.
  • Despite expressing all components of the TRAIL pathway, freshly isolated primary esthesioneuroblastoma cells were completely resistant to TRAIL-induced apoptosis.
  • This is the first report on the highly synergistic induction of apoptosis in primary esthesioneuroblastoma cells by Bortezomib and TRAIL.
  • This combination, therefore, represents a promising novel therapeutic option for esthesioneuroblastoma.
  • [MeSH-major] Antineoplastic Agents / pharmacology. Apoptosis / drug effects. Boronic Acids / pharmacology. Esthesioneuroblastoma, Olfactory / metabolism. Nose Neoplasms / metabolism. Pyrazines / pharmacology. TNF-Related Apoptosis-Inducing Ligand / pharmacology

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • Hazardous Substances Data Bank. BORTEZOMIB .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Mol Med (Berl). 2007 Sep;85(9):923-35 [17437073.001]
  • [Cites] J Biol Chem. 2002 Jul 12;277(28):25020-5 [11976344.001]
  • [Cites] Neurosurgery. 1993 May;32(5):706-14; discussion 714-5 [8492845.001]
  • [Cites] No Shinkei Geka. 2007 May;35(5):503-8 [17491347.001]
  • [Cites] J Clin Invest. 2008 Jun;118(6):1979-90 [18523647.001]
  • [Cites] Otolaryngol Head Neck Surg. 2008 Nov;139(5):708-12 [18984268.001]
  • [Cites] Cancer Lett. 2002 Jun 28;180(2):107-19 [12175541.001]
  • [Cites] J Neurooncol. 2008 Nov;90(2):201-4 [18633576.001]
  • [Cites] Cell Death Differ. 2004 Jul;11 Suppl 1:S86-96 [15105837.001]
  • [Cites] Clin Cancer Res. 2001 May;7(5):1362-9 [11350907.001]
  • [Cites] Exp Cell Res. 2000 Apr 10;256(1):58-66 [10739652.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 Jan;290(1):G129-36 [16166346.001]
  • [Cites] Am J Pediatr Hematol Oncol. 1991 Spring;13(1):62-70 [2029081.001]
  • [Cites] Head Neck. 2005 Feb;27(2):138-49 [15654688.001]
  • [Cites] Lancet Oncol. 2001 Nov;2(11):683-90 [11902539.001]
  • [Cites] Hepatology. 2007 Mar;45(3):649-58 [17326159.001]
  • [Cites] Oncogene. 2006 Nov 30;25(56):7434-9 [16751802.001]
  • [Cites] Head Neck. 2008 Dec;30(12):1607-14 [18798301.001]
  • [Cites] Cancer Res. 2003 Mar 1;63(5):1122-9 [12615731.001]
  • [Cites] Nat Med. 2002 Aug;8(8):808-15 [12118245.001]
  • [Cites] Cancer Lett. 2009 Nov 18;285(1):1-5 [19299078.001]
  • [Cites] Clin Cancer Res. 2006 Apr 15;12 (8):2640-6 [16638878.001]
  • [Cites] Oncogene. 2008 May 15;27(22):3211-20 [18084329.001]
  • [Cites] Oncogene. 2003 Aug 7;22(32):4953-63 [12902978.001]
  • [Cites] Cancer Res. 2001 Feb 1;61(3):1162-70 [11221847.001]
  • [Cites] Clin Cancer Res. 2007 Jun 1;13(11):3403-12 [17545549.001]
  • [Cites] J Exp Ther Oncol. 2008;7(2):135-45 [18771087.001]
  • [Cites] Toxicol Lett. 2003 Apr 4;139(2-3):89-97 [12628743.001]
  • [Cites] Hepatology. 2005 Sep;42(3):588-97 [16037944.001]
  • [Cites] Cancer Genet Cytogenet. 2007 Mar;173(2):89-96 [17321323.001]
  • [Cites] Cancer. 2005 Oct 1;104(7):1487-96 [16080161.001]
  • [Cites] Curr Opin Otolaryngol Head Neck Surg. 2003 Apr;11(2):112-8 [14515089.001]
  • [Cites] Immunity. 2000 Jun;12(6):599-609 [10894160.001]
  • [Cites] Chin Med J (Engl). 2007 Feb 5;120(3):224-7 [17355826.001]
  • [Cites] Rev Recent Clin Trials. 2009 Jan;4(1):34-41 [19149761.001]
  • (PMID = 19768634.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Grant] United Kingdom / Cancer Research UK / / 10950
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Boronic Acids; 0 / Pyrazines; 0 / TNF-Related Apoptosis-Inducing Ligand; 69G8BD63PP / Bortezomib
  •  go-up   go-down


95. Schwartz TH, Fraser JF, Brown S, Tabaee A, Kacker A, Anand VK: Endoscopic cranial base surgery: classification of operative approaches. Neurosurgery; 2008 May;62(5):991-1002; discussion 1002-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We prospectively compiled a comprehensive database of our endonasal endoscopic operations, detailing the nasal sinus transgressed, the cranial base approach, and the intracranial target for the first 150 consecutive cases performed at our institution.
  • RESULTS: We categorized the endonasal endoscopic cranial base operations into four nasal corridors, nine cranial base approaches, and 13 intracranial targets.
  • Pathology encountered included pituitary tumor (50%), meningocele/encephalocele (14%), craniopharyngioma and Rathke cleft cyst (10%), meningioma (8%), chordoma (5%), esthesioneuroblastoma (2%), and other (11%).
  • A clear understanding of the possible approaches is facilitated by an awareness of the nasal corridors and intracranial targets.
  • [MeSH-minor] Female. Humans. Male. Nasal Cavity / surgery

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Endoscopy.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18580797.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


96. Prasad KC, Kumar A, Prasad SC, Jain D: Endoscopic-assisted excision of esthesioneuroblastoma. J Craniofac Surg; 2007 Sep;18(5):1034-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic-assisted excision of esthesioneuroblastoma.
  • The purpose of this article is to report a case of esthesioneuroblastoma involving the bilateral paranasal sinuses, which was excised using an endoscopic-assisted transfacial approach.
  • A patient presented with nasal swelling and left-sided nasal obstruction, epistaxis, and diplopia.
  • Examination revealed broadening of the nasal dorsum with a fleshy pink mass in both nasal cavities.
  • Computed tomographic scan showed a mass involving the nasal cavity and paranasal sinuses on both sides.
  • The tumor was diagnosed as group C esthesioneuroblastoma.
  • On Waroff staining, Hispathology slides suggested esthesioneuroblastoma.
  • The patient was asymptomatic for 1 year, following which he developed infection of the nasal cavity for which he had no form of treatment.
  • He subsequently developed maggots in the nasal cavity after which he died.
  • An endoscopic resection of the cribriform plate from the nasal cavity without a formal craniofacial resection can be safely performed with oncologic safety.
  • [MeSH-major] Endoscopy / methods. Esthesioneuroblastoma, Olfactory / surgery. Nasal Cavity / surgery. Nose Neoplasms / surgery

  • Genetic Alliance. consumer health - Esthesioneuroblastoma.
  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17912077.001).
  • [ISSN] 1049-2275
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Yamate J, Izawa T, Ogata K, Kobayashi O, Okajima R, Kuwamura M, Kotani T, Aoki M: Olfactory neuroblastoma in a horse. J Vet Med Sci; 2006 May;68(5):495-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Olfactory neuroblastoma in a horse.
  • An 11-year-old thoroughbred gelding was euthanatized because of right nasal cavity tumor.
  • Based on these findings, this tumor was diagnosed as an olfactory neuroblastoma.

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16757894.001).
  • [ISSN] 0916-7250
  • [Journal-full-title] The Journal of veterinary medical science
  • [ISO-abbreviation] J. Vet. Med. Sci.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


98. Wojtarowicz A, Radkowski AS, Tyralik D, Dobroś W: [Extensive olfactory neuroblastoma of the nasal cavity and paranasal sinuses]. Przegl Lek; 2010;67(5):442-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Extensive olfactory neuroblastoma of the nasal cavity and paranasal sinuses].
  • [Transliterated title] Rozległy nerwiak w chowy zarodkowy jamy nosa i zatok przynosowych.
  • The authors describe a clinical case of extensive olfactory neuroblastoma, comprehensive the nasal cavity, paranasal sinuses and orbit who was treated in Otolaryngology Department of the Regional Hospital in Tarnów.
  • Diagnostic difficulties in olfactory neuroblastoma recognition and value of the immunohistochemical examinations were emphasized.
  • [MeSH-major] Neuroblastoma / diagnosis. Nose Neoplasms / diagnosis. Orbital Neoplasms / diagnosis. Paranasal Sinus Neoplasms / diagnosis
  • [MeSH-minor] Aged. Disease-Free Survival. Female. Humans. Radiotherapy, Adjuvant

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20684358.001).
  • [ISSN] 0033-2240
  • [Journal-full-title] Przegla̧d lekarski
  • [ISO-abbreviation] Prz. Lek.
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


99. Kryzanski JT, Annino DJ, Gopal H, Heilman CB: Low complication rates of cranial and craniofacial approaches to midline anterior skull base lesions. Skull Base; 2008 Jul;18(4):229-41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The remainder had frontoethmoidal cancer, mucoceles/invasive nasal polyps, encephalocele, esthesioneuroblastoma, anterior falx dermoid cyst with a nasal sinus tract, or invasive pituitary adenoma.
  • When possible, the dura was repaired before entering the nasal cavity.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg. 1985 Oct;150(4):406-13 [4051102.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1986 Jul;112(7):745-9 [3707737.001]
  • [Cites] Plast Reconstr Surg. 1984 Jul;74(1):10-8 [6739582.001]
  • [Cites] Laryngoscope. 1979 Jul;89(7 Pt 1):1077-91 [449551.001]
  • [Cites] Am J Surg. 1975 Oct;130(4):463-9 [1166938.001]
  • [Cites] Neurosurgery. 2004 Jul;55(1):239-44; discussion 244-6 [15214996.001]
  • [Cites] Laryngoscope. 2002 Mar;112(3):424-7 [12148847.001]
  • [Cites] Minim Invasive Neurosurg. 2001 Dec;44(4):190-3 [11830775.001]
  • [Cites] J Neurosurg. 2000 Oct;93(4):711-4 [11014555.001]
  • [Cites] J Craniomaxillofac Surg. 1999 Aug;27(4):228-34 [10626256.001]
  • [Cites] Laryngoscope. 1999 Dec;109(12):1959-66 [10591355.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1997 Jul;123(7):738-42 [9236594.001]
  • [Cites] J Neurosurg. 2007 Mar;106(3):400-6 [17367062.001]
  • [Cites] Neurosurgery. 2007 Jan;60(1):46-58; discussion 58-9 [17228252.001]
  • [Cites] Skull Base Surg. 1999;9(2):95-100 [17171124.001]
  • [Cites] Skull Base Surg. 1999;9(1):41-6 [17171080.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2006 Jul;263(7):647-52 [16538505.001]
  • [Cites] Head Neck. 2005 Jul;27(7):575-84 [15825201.001]
  • [Cites] J Neurosurg. 2005 May;102(5):832-41 [15926706.001]
  • [Cites] Am J Surg. 1963 Nov;106:698-703 [14078719.001]
  • [Cites] J Neurosurg. 1999 Jul;91(1):124-7 [10389891.001]
  • [Cites] Head Neck. 1999 Jan;21(1):12-20 [9890346.001]
  • [Cites] J Surg Oncol. 1998 Dec;69(4):275-84 [9881946.001]
  • [Cites] J Neurosurg. 1995 Jun;82(6):1002-10 [7760173.001]
  • [Cites] Am J Surg. 1994 Nov;168(5):481-4 [7977980.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1994 Nov;120(11):1203-8 [7917203.001]
  • [Cites] Otolaryngol Head Neck Surg. 1994 Jun;110(6):539-46 [8208569.001]
  • [Cites] J Neurosurg. 1993 Nov;79(5):782-6 [8410261.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1993 Apr;119(4):385-93 [8457302.001]
  • [Cites] Otolaryngol Head Neck Surg. 1992 Oct;107(4):564-9 [1437188.001]
  • [Cites] Ann Otolaryngol Chir Cervicofac. 1991;108(5):292-7 [1759745.001]
  • [Cites] Laryngoscope. 1991 Mar;101(3):240-4 [2000010.001]
  • [Cites] Acta Neurochir (Wien). 1988;92(1-4):83-92 [3270999.001]
  • [Cites] Plast Reconstr Surg. 1986 Sep;78(3):309-17 [3737755.001]
  • [Cites] Plast Reconstr Surg. 1986 Jun;77(6):905-10 [3714887.001]
  • [Cites] Am J Surg. 1980 Nov;140(5):618-24 [7435819.001]
  • (PMID = 19119338.001).
  • [ISSN] 1531-5010
  • [Journal-full-title] Skull base : official journal of North American Skull Base Society ... [et al.]
  • [ISO-abbreviation] Skull Base
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2467480
  • [Keywords] NOTNLM ; Anterior skull base / cerebrospinal fluid leak / complications / craniofacial approach / meningioma / skull base surgery
  •  go-up   go-down


100. Wang SY, Zhu L, Li SM, Lin L, Zheng SX, Wu YF, Zhu XZ: [Sinonasal teratocarcinosarcoma: a clinical, radiologic and pathologic study of 5 cases]. Zhonghua Bing Li Xue Za Zhi; 2007 Aug;36(8):534-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To study the clinical, radiologic and pathologic features, as well as differential diagnosis of teratocarcinosarcoma in nasal cavity and paranasal sinuses.
  • The clinical presentation was nasal obstruction, epistaxis and headache.
  • Computed tomography showed a homogeneous nasal mass with obturation of sinuses.
  • The initial biopsy diagnosis included capillary hemangioma, olfactory neuroblastoma, craniopharyngioma and malignant mixed tumor.
  • CONCLUSIONS: Sinonasal teratocarcinosarcoma is a rare and highly malignant tumor occurring in sinonasal tract.
  • "Fetal-type" clear cells, squamous epithelium and immature neuroepithelium represent important histologic characteristics useful in diagnosis.
  • [MeSH-major] Carcinosarcoma / pathology. Nasal Cavity. Nose Neoplasms / pathology. Paranasal Sinus Neoplasms / pathology. Teratocarcinoma / pathology
  • [MeSH-minor] Adult. Follow-Up Studies. Humans. Keratins / metabolism. Lymphatic Metastasis. Male. Mucin-1 / metabolism. Neck Dissection. Neoplasm Recurrence, Local

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17980101.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Mucin-1; 68238-35-7 / Keratins
  •  go-up   go-down






Advertisement